≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other diseases of upper respiratory tract

DOID EFO Endpoint Browser PheWeb

J10_UPPERDIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J30-J39
  • Cause of death: ICD-10 — J30-J39

2 out of 7 registries used, show all original rules.

89479

4. Check minimum number of events

None

89479

5. Include endpoints

132964

6. Filter based on genotype QC (FinnGen only)

132964

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1214797 594962 615238
Only index persons 1106993 553534 553459
Unadjusted period prevalence (%)
Whole population 17.07 17.04 17.19
Only index persons 20.74 20.35 21.13
Median age at first event (years)
Whole population 19.50 21.13 17.78
Only index persons 19.75 21.45 18.05

-FinnGen-

Key figures

All Female Male
Number of individuals 132964 79900 53064
Unadjusted period prevalence (%) 25.70 27.23 23.39
Median age at first event (years) 29.95 27.17 34.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
6801
Matched controls
49120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
+∞
323.0
668
*
J31.0
ICD-10 Finland
Chronic rhinitis
28.5
323.0
716
202
J37.0
ICD-10 Finland
Chronic laryngitis
144.7
323.0
432
23
50499
ICD-8 Finland
Deflected nasal septum
+∞
323.0
463
*
R01AD08
ATC
fluticasone; nasal
4.6
323.0
1878
3759
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
53.6
323.0
749
113
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
219.3
323.0
399
14
J33.0
ICD-10 Finland
Polyp of nasal cavity
254.3
323.0
432
13
J34.2
ICD-10 Finland
Deviated nasal septum
380.2
323.0
398
8
R01AD09
ATC
mometasone; nasal
3.8
323.0
2519
6555
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
482.3
284.6
319
5
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
+∞
278.0
301
*
R01AD01
ATC
beclometasone; nasal
4.3
263.2
1157
2233
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
+∞
253.7
275
*
J33.8
ICD-10 Finland
Other polyp of sinus
309.6
218.3
249
6
R01BA52
ATC
pseudoephedrine, combinations; oral
3.0
210.7
1518
4292
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
+∞
203.6
221
*
J01AA02
ATC
doxycycline; systemic
2.3
202.7
5010
26823
J01FA10
ATC
azithromycin; systemic
2.4
202.4
2508
9687
R03AC02
ATC
salbutamol; inhalant
2.2
197.0
3182
13914
UDH02
NOMESCO Finland
Rhinopharyngoscopy
8.1
190.0
482
460
TDM10
NOMESCO Finland
Puncture of maxillary antrum
18.5
179.9
309
126
R01AD05
ATC
budesonide; nasal
5.3
177.2
618
912
DHB20
NOMESCO Finland
Polypectomy of internal nose
152.6
172.6
205
10
J01CA04
ATC
amoxicillin; systemic
2.1
168.6
4496
23722
R01AD12
ATC
fluticasone furoate; nasal
3.3
168.1
999
2424
DJD20
NOMESCO Finland
Plastic repair of septum of nose
178.3
163.4
192
8
4226
FHL
Posterior radical surgery and possible etmoidectomy
158.5
162.1
192
9
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.6
161.0
863
1925
50300
ICD-8 Finland
Chronic sinusitis, Maxillaris cum empyemate
+∞
157.3
171
*
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
225.0
156.1
181
6
4222
FHL
Endonasal etmoidectomy
426.2
153.3
173
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
152.5
2461
10394
J36
ICD-10 Finland
Peritonsillar abscess
219.8
152.5
177
6
H02AB06
ATC
prednisolone; systemic
2.0
150.8
3301
15767
J35.0
ICD-10 Finland
Chronic tonsillitis
395.8
142.3
161
*
1420
FHL
Laryngomicroscopy
22.5
142.0
229
76
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
141.0
1366
4486
4211
FHL
Transeptal septal resection and reconstruction
1153.1
138.5
153
*
R03DC03
ATC
montelukast; oral
3.2
134.7
848
2122
4452
FHL
Tonsil surgery
78.2
133.6
169
16
R06AE07
ATC
cetirizine; oral
2.1
132.1
2125
8832
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
+∞
125.9
137
*
50709
ICD-8 Finland
Hay fever, Unspecified
+∞
125.9
137
*
J30.0
ICD-10 Finland
Vasomotor rhinitis
11.1
125.2
264
178
50808
ICD-8 Finland
Other diseases of upper respiratory tract, Alii definiti
+∞
120.3
131
*
50503
ICD-8 Finland
Nasal polyp, Ethmoidalis
+∞
117.6
128
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.1
116.9
1675
6565
A02BC05
ATC
esomeprazole; systemic
1.9
114.3
2375
10763
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
+∞
113.9
124
*
J38.3
ICD-10 Finland
Other diseases of vocal cords
122.4
110.1
133
8
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
3.5
109.1
575
1248
A02BC02
ATC
pantoprazole; systemic
1.8
108.2
3964
21592
4224
FHL
Endonasal anthrostomy
155.7
107.1
127
6
J01FA06
ATC
roxithromycin; oral
1.8
103.4
2544
12116
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
177.9
103.0
121
5
UDQ12
NOMESCO Finland
Flexible laryngoscopy
5.2
97.4
338
489
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
+∞
97.3
106
*
R03BA02
ATC
budesonide; inhalant
2.2
97.0
1143
4058
50199
ICD-8 Finland
Peritonsillar abscess
+∞
96.4
105
*
J01DB01
ATC
cefalexin; oral
1.7
96.2
4405
25235
4740A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Chronic tonsillitis
+∞
94.5
103
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
11.3
90.0
187
122
R01AD11
ATC
triamcinolone; nasal
3.5
90.0
486
1071
UDM02
NOMESCO Finland
Sinoscopy
19.8
89.8
150
56
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
687.6
84.3
94
*
R03BA05
ATC
fluticasone; inhalant
2.1
82.8
1117
4184
50609
ICD-8 Finland
Chronic laryngitis, Unspecified
+∞
82.6
90
*
50708
ICD-8 Finland
Hay fever, Alia definita
+∞
82.6
90
*
R03BA01
ATC
beclometasone; inhalant
2.1
80.9
1042
3822
DHB50
NOMESCO Finland
Turbinoplasty
228.4
80.3
93
*
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
68.7
80.3
103
11
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
21.7
80.3
130
44
J01DA01
ATC
[U] cefalexin; systemic
1.6
80.0
3915
22230
50304
ICD-8 Finland
Chronic sinusitis, Ethmoidalis
+∞
79.8
87
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
79.6
2786
14428
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
79.0
1466
6211
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
78.8
1800
8190
J01FA09
ATC
clarithromycin; systemic
2.0
78.4
1275
5140
N02BE01
ATC
paracetamol; systemic, rectal
1.7
78.2
5028
30686
J32.4
ICD-10 Finland
Chronic pansinusitis
324.4
78.1
89
*
M03BX02
ATC
tizanidine; oral
1.7
77.1
2161
10465
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.3
74.4
429
990
G47.3
ICD-10 Finland
Sleep apnoea
2.5
74.0
663
2027
R03AC03
ATC
terbutaline; inhalant
2.2
72.2
867
3069
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
71.6
2787
14717
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
71.6
2393
12126
R05
ICD-10 Finland
Cough
2.1
71.5
1021
3893
A02BC03
ATC
lansoprazole; oral
1.7
71.2
2070
10080
J02AC01
ATC
fluconazole; systemic
1.8
70.4
1518
6734
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
69.5
2228
11134
A98
ICPC
Health maint/preventive medicine
1.6
68.3
4301
25528
R03AK07
ATC
formoterol and budesonide; inhalant
2.1
68.2
886
3242
R06AX27
ATC
desloratadine; oral
2.2
68.0
798
2789
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
554.2
67.9
76
*
EMB10
NOMESCO Finland
Tonsillectomy
27.7
67.4
102
27
4221
FHL
Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room
77.7
67.4
85
8
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
66.5
1382
6039
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
65.7
1731
8147
J39.2
ICD-10 Finland
Other diseases of pharynx
41.6
65.7
91
16
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
64.8
1155
4780
J30.3
ICD-10 Finland
Other allergic rhinitis
12.9
64.5
126
72
M01AH05
ATC
etoricoxib; oral
1.6
64.3
2095
10465
R05
ICPC
Cough
2.0
64.3
1004
3955
M79.6
ICD-10 Finland
Pain in limb
1.7
64.2
1759
8364
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
64.0
1917
9352
J45.1
ICD-10 Finland
Nonallergic asthma
2.7
63.8
503
1428
H02AB04
ATC
methylprednisolone; systemic
2.0
63.6
984
3857
A02BC01
ATC
omeprazole; systemic
1.6
63.4
2143
10799
R96
ICPC
Asthma
2.7
62.9
475
1313
J01CE02
ATC
phenoxymethylpenicillin; oral
1.6
62.7
3054
16867
4750B
ICD-9 Finland
Peritonsillar abscess[PERITONSILLITIS ABSCEDENS]
+∞
62.3
68
*
R06.0
ICD-10 Finland
Dyspnoea
1.7
61.9
1867
9105
R21
ICPC
Throat symptom/complaint
2.6
61.8
507
1472
4212
FHL
Maxillapremmaxilla opening septum resection and reconstruction
502.5
61.5
69
*
4784A
ICD-9 Finland
Other diseases of upper respiratory tract, Polyp of vocal cord or larynx[POLYPUS PLICAE VOCALIS]
+∞
61.4
67
*
DMB10
NOMESCO Finland
Radical maxillary antrotomy
108.0
60.8
74
5
WX110
NOMESCO Finland
Local anesthesy
1.6
60.8
2656
14253
J45
ICD-10 Finland
Asthma
2.6
60.5
495
1432
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
170.2
59.6
70
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
59.3
1871
9219
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
58.9
1634
7763
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
57.8
1727
8369
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.7
57.7
1597
7576
S18
ICPC
Laceration/cut
1.6
56.7
2112
10840
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
56.0
1777
8743
KMAK
NOMESCO Finland
NA
1.6
54.7
1744
8581
N02AX02
ATC
tramadol; systemic, rectal
1.5
54.6
2562
13870
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
8.8
54.4
128
107
H02AB07
ATC
prednisone; oral
1.8
54.3
1093
4687
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
54.2
1357
6235
N03AX16
ATC
pregabalin; oral
1.7
53.9
1286
5822
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
53.6
1241
5566
J33.9
ICD-10 Finland
Nasal polyp, unspecified
30.3
53.6
79
19
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
53.2
4036
24243
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
53.1
1675
8206
J01DA06
ATC
[U] cefuroxime; systemic
2.0
52.5
829
3260
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
11.6
51.7
105
66
4732A
ICD-9 Finland
Chronic sinusitis, Ethmoidal
+∞
51.3
56
*
K02.1
ICD-10 Finland
Caries of dentine
1.6
51.3
1700
8423
J01MA02
ATC
ciprofloxacin; systemic
1.5
51.0
2679
14807
S01GX01
ATC
cromoglicic acid; ophthalmic
2.1
51.0
636
2269
P01AB01
ATC
metronidazole; oral, rectal
1.6
50.9
1785
8970
UJF32
NOMESCO Finland
Coloscopy
1.6
50.9
1625
7970
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.5
50.4
437
1305
R06AX22
ATC
ebastine; oral
2.2
50.2
590
2049
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
50.1
1180
5308
R01AX03
ATC
ipratropium bromide; nasal
3.3
49.9
284
648
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.6
49.7
1704
8506
L17
ICPC
Foot/toe symptom/complaint
1.7
49.5
1241
5684
R13
ICD-10 Finland
Dysphagia
2.3
48.8
487
1565
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
48.7
1368
6470
M54.5
ICD-10 Finland
Low back pain
1.6
48.2
1434
6887
M25.5
ICD-10 Finland
Pain in joint
1.8
48.1
986
4240
R03AC12
ATC
salmeterol; inhalant
2.3
47.9
516
1721
E0000UV
ATC
NA
1.5
47.8
2026
10627
4239
FHL
Other measure in this category
135.9
47.0
56
*
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
45.9
1483
7262
R09
ICPC
Sinus symptom/complaint
3.9
45.9
207
391
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
49.4
45.6
61
9
A07AA02
ATC
nystatin; oral
2.2
45.5
528
1821
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
45.4
1890
9844
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
44.9
2350
12873
R03BA08
ATC
ciclesonide; inhalant
2.8
44.7
322
862
A01AB09
ATC
miconazole; local oral
1.9
44.6
717
2828
M01AX05
ATC
glucosamine; oral
1.6
44.6
1511
7485
SPAT1325
SPAT
Vaccination
1.5
44.2
2239
12169
4225
FHL
Exploratory buccal opening, includes polyps and cyst removal
362.6
44.2
50
*
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
43.7
2196
11906
R05FB02
ATC
cough suppressants and expectorants
1.5
43.5
2496
13912
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
26.7
43.5
66
18
M01AB05
ATC
diclofenac; systemic, rectal
1.4
43.3
2953
17033
C07AB07
ATC
bisoprolol; oral
1.4
43.2
3735
22558
49300
ICD-8 Finland
Asthma, bronchiale
3.2
43.0
253
592
R74
ICPC
Upper respiratory infection acute
2.0
42.8
632
2413
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
41.9
938
4132
UDQ22
NOMESCO Finland
Microlaryngoscopy
8.7
41.8
98
82
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.7
41.6
1126
5242
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
41.6
1101
5096
M48.0
ICD-10 Finland
Spinal stenosis
1.7
41.5
959
4266
SPAT1153
SPAT
Removal of sutures
1.6
41.4
1531
7725
A02BA02
ATC
ranitidine; systemic
1.5
41.3
1630
8351
R06AE09
ATC
levocetirizine; oral
2.2
41.0
452
1523
R06.5
ICD-10 Finland
Mouth breathing
3.1
40.9
250
600
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.3
40.5
163
277
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
40.0
1054
4865
L03
ICPC
Low back symptom/complaint
1.7
39.9
1004
4573
R06AX13
ATC
loratadine; oral
2.1
39.8
511
1839
R42
ICD-10 Finland
Dizziness and giddiness
1.5
38.8
1676
8743
XKD00
NOMESCO Finland
Uroflowmetry
1.6
38.8
1248
6073
ZXA05
NOMESCO Finland
Left side
1.5
38.8
1795
9506
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
38.5
3561
21560
M03BC51
ATC
orphenadrine, combinations; systemic
1.7
38.5
1016
4688
R03AC13
ATC
formoterol; inhalant
2.3
38.4
396
1292
R51.80
ICD-10 Finland
Headache
2.0
38.2
552
2084
R02
ICPC
Shortness of breath/dyspnoea
1.8
38.1
761
3228
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
38.0
197
419
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
37.6
1135
5425
N06AX11
ATC
mirtazapine; oral
1.5
37.5
1704
8976
ZXA10
NOMESCO Finland
Bilateral
1.6
37.1
1326
6612
J31.2
ICD-10 Finland
Chronic pharyngitis
41.2
37.1
51
9
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.6
36.8
1270
6276
N05CF01
ATC
zopiclone; oral
1.4
36.7
2507
14313
M02AA07
ATC
piroxicam; topical
1.4
36.4
2377
13454
SPAT1263
SPAT
Sampling
1.4
36.4
2261
12677
J01FA15
ATC
telithromycin; oral
2.4
35.6
335
1044
R03BB04
ATC
tiotropium bromide; inhalant
1.6
35.5
965
4480
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
35.4
2087
11564
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
12.7
35.1
68
39
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
35.1
2936
17345
M01AE02
ATC
naproxen; oral, rectal
1.4
35.0
2378
13529
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
35.0
871
3944
J45.8
ICD-10 Finland
Mixed asthma
2.9
34.7
232
593
J38.7
ICD-10 Finland
Other diseases of larynx
78.1
34.4
43
*
J32.1
ICD-10 Finland
Chronic frontal sinusitis
+∞
33.9
37
*
L08
ICPC
Shoulder symptom/complaint
1.7
33.9
773
3410
R49.08
ICD-10 Finland
Other specified dysphonia
5.7
33.8
105
134
L01
ICPC
Neck symptom/complaint
1.9
33.8
524
2031
-1
NOMESCO Finland
NA
1.6
33.8
1004
4767
WX002
NOMESCO Finland
Sedation and analgesia
1.6
33.5
1064
5138
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
33.3
641
2679
G04CA02
ATC
tamsulosin; oral
1.4
33.1
2154
12125
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.4
33.1
1847
10102
XF402
NOMESCO Finland
ECG with work load test
1.8
32.9
624
2594
J35.1
ICD-10 Finland
Hypertrophy of tonsils
141.6
32.9
39
*
J01FF01
ATC
clindamycin; systemic
1.5
32.9
1264
6384
UKC02
NOMESCO Finland
Cystoscopy
1.5
32.8
1364
7013
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
7.8
32.8
82
77
M70.6
ICD-10 Finland
Trochanteric bursitis
1.8
32.7
625
2606
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
32.6
863
3969
G44.2
ICD-10 Finland
Tension-type headache
2.0
32.6
472
1782
J01DA08
ATC
[U] cefaclor; oral
2.2
32.6
372
1270
WX320
NOMESCO Finland
Spinalanesthesy
1.5
32.2
1196
5992
ZXA00
NOMESCO Finland
Right side
1.4
32.1
1836
10074
J39.0
ICD-10 Finland
Retropharyngeal and parapharyngeal abscess
+∞
32.1
35
*
J35.2
ICD-10 Finland
Hypertrophy of adenoids
+∞
32.1
35
*
J38.4
ICD-10 Finland
Oedema of larynx
+∞
32.1
35
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.1
32.0
393
1386
R35
ICD-10 Finland
Polyuria
2.0
31.9
434
1598
R49.01
ICD-10 Finland
Functional dysphonia
3.7
31.6
152
305
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
3.4
31.5
164
351
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
31.4
405
1458
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
31.3
1466
7721
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
31.1
4157
26321
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
31.0
1155
5786
J20
ICD-10 Finland
Acute bronchitis
2.0
30.9
440
1649
N03AX12
ATC
gabapentin; oral
1.7
30.7
708
3128
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
30.5
2282
13119
J46
ICD-10 Finland
Status asthmaticus
2.9
30.4
206
532
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
30.3
1210
6153
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
30.3
1208
6143
4781C
ICD-9 Finland
Other diseases of upper respiratory tract, Other diseases of nasal cavity and sinuses[CYSTA SINUS MAXILLARIS]
+∞
30.2
33
*
R03DA04
ATC
theophylline; systemic, rectal
1.7
30.1
746
3366
L82
ICD-10 Finland
Seborrhoeic keratosis
1.7
29.9
707
3146
H29
ICPC
Ear symptom/complaint other
1.8
29.8
540
2208
Z01.2
ICD-10 Finland
Dental examination
1.5
29.6
1082
5389
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
6.0
29.4
87
105
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
29.3
859
4051
4719X
ICD-9 Finland
Nasal polyps, Unspecified nasal polyp
+∞
29.3
32
*
J31.1
ICD-10 Finland
Chronic nasopharyngitis
22.3
29.1
46
15
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
29.0
1339
7017
L15
ICPC
Knee symptom/complaint
1.6
28.9
833
3910
D07AC01
ATC
betamethasone; topical
1.4
28.9
1712
9421
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
28.7
600
2573
WX290
NOMESCO Finland
Other blockade of nerve
1.6
28.6
858
4069
R07.0
ICD-10 Finland
Pain in throat
3.0
28.6
181
445
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
28.5
507
2060
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
28.4
635
2775
C08CA01
ATC
amlodipine; oral
1.4
28.3
2559
15128
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
28.3
898
4320
J38.2
ICD-10 Finland
Nodules of vocal cords
84.7
28.3
35
*
D01AE16
ATC
amorolfine; topical
1.7
28.2
654
2891
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
28.2
567
2400
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.7
28.1
640
2816
G04BD12
ATC
mirabegron; oral
1.7
28.1
654
2894
M79.1
ICD-10 Finland
Myalgia
1.9
27.9
455
1792
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
27.8
1309
6878
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
6.3
27.7
79
91
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.7
27.5
687
3102
B01AB05
ATC
enoxaparin; parenteral
1.4
27.4
1629
8950
DPA30
NOMESCO Finland
Sphenotomy
52.3
27.4
36
5
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
27.3
1193
6170
UDC00
NOMESCO Finland
Ear microscopy
2.0
27.2
376
1391
M01AC06
ATC
meloxicam; systemic, rectal
1.4
27.0
1641
9050
C05AA08
ATC
fluocortolone; rectal, topical
1.6
27.0
735
3398
A02BC04
ATC
rabeprazole; oral
2.2
26.9
305
1038
DHA10
NOMESCO Finland
Biopsy of cavity of nose
11.5
26.9
54
34
L13
ICPC
Hip symptom/complaint
1.6
26.9
813
3862
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
26.9
1111
5675
SPAT1301
SPAT
No procedures
1.4
26.8
1944
11055
A02BA04
ATC
nizatidine; systemic
1.6
26.8
715
3284
R4110
NOMESCO Finland
Physiotherapy
1.4
26.6
1315
6973
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
26.5
2953
17976
C09CA06
ATC
candesartan; oral
1.5
26.5
1018
5117
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
26.4
1898
10775
M01AH02
ATC
rofecoxib; oral
1.6
26.4
882
4291
C10AA05
ATC
atorvastatin; oral
1.4
26.3
2243
13094
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
26.3
735
3419
ZXC60
NOMESCO Finland
Application of heat
22.9
26.2
41
13
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.6
26.2
718
3324
R01AC01
ATC
cromoglicic acid; nasal
4.2
26.1
107
187
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
3.0
26.1
159
384
J01MA12
ATC
levofloxacin; systemic
1.5
26.0
1253
6604
C10AA07
ATC
rosuvastatin; oral
1.5
25.9
972
4855
DQA10
NOMESCO Finland
Biopsy of larynx
10.3
25.9
55
39
A03FA02
ATC
cisapride; oral, rectal
1.6
25.9
680
3110
S29
ICPC
Skin symptom/complaint other
1.6
25.9
783
3718
M01AH01
ATC
celecoxib; oral (coxibs)
1.5
25.8
957
4770
K30
ICD-10 Finland
Functional dyspepsia
1.9
25.7
430
1711
XQ800
NOMESCO Finland
Prick test
3.2
25.7
143
323
4720C
ICD-9 Finland
Chronic pharyngitis and nasopharyngitis, Chronic rhinitis[RHINITIS VASOMOTORICA]
+∞
25.6
28
*
50509
ICD-8 Finland
Nasal polyp, Unspecified
+∞
25.6
28
*
Z71.8
ICD-10 Finland
Other specified counselling
1.5
25.5
875
4281
J02AC02
ATC
itraconazole; systemic
1.6
25.4
673
3086
D01BA02
ATC
terbinafine; oral; topical
1.5
25.3
1071
5493
AA1AD
NOMESCO Finland
CT of head and brain
1.4
25.0
1695
9509
D07AC13
ATC
mometasone; topical
1.4
24.8
1369
7397
R03BC03
ATC
nedocromil; inhalant
2.1
24.7
320
1153
50809
ICD-8 Finland
Other diseases of upper respiratory tract, Unspecified
+∞
24.7
27
*
50501
ICD-8 Finland
Nasal polyp, Maxillaris
+∞
24.7
27
*
50600
ICD-8 Finland
NA
+∞
24.7
27
*
C10AA01
ATC
simvastatin; oral
1.3
24.6
3361
20982
SPAT1312
SPAT
General health counselling
1.4
24.5
1311
7042
G04CA01
ATC
alfuzosin; oral
1.6
24.5
816
3964
A01AB04
ATC
amphotericin B; local oral
1.8
24.5
427
1723
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
24.3
713
3354
J32.3
ICD-10 Finland
Chronic sphenoidal sinusitis
203.8
24.2
28
*
DNB10
NOMESCO Finland
Endonasal ethmoidectomy
203.8
24.2
28
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
24.2
277
949
U02
ICPC
Urinary frequency/urgency
1.6
24.1
640
2933
UDQ02
NOMESCO Finland
Direct laryngoscopy
7.7
24.1
60
57
N39.3
ICD-10 Finland
Stress incontinence
2.0
24.0
311
1123
R75
ICPC
Sinusitis acute/chronic
3.6
24.0
118
243
A03CA02
ATC
clidinium and psycholeptics; oral
1.7
24.0
505
2166
D82
ICPC
Teeth/gum disease
1.6
23.8
767
3694
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.6
23.8
715
3385
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.4
23.7
214
654
R07.3
ICD-10 Finland
Other chest pain
1.7
23.7
516
2236
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
23.7
1573
8777
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
23.6
612
2788
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
23.6
1720
9752
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.1
23.5
276
955
D19
ICPC
Teeth/gum symptom/complaint
1.6
23.4
601
2730
SPAT1310
SPAT
Counselling related to known health issue
1.4
23.4
1383
7557
VALMI
NOMESCO Finland
NA
1.6
23.4
680
3192
R03AK08
ATC
formoterol and beclometasone; inhalant
3.0
23.3
144
352
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
4.4
23.1
90
150
4252
FHL
Resection, coagulation or cryo on the cortex and nasal mucosa
101.5
23.1
28
*
R60.0
ICD-10 Finland
Localized oedema
1.5
22.8
772
3760
H26.4
ICD-10 Finland
After-cataract
1.5
22.7
977
5017
L12
ICPC
Hand/finger symptom/complaint
1.7
22.7
510
2229
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.9
22.7
360
1406
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.5
22.6
767
3736
H01
ICPC
Ear pain/earache
2.0
22.6
318
1186
H02
ICPC
Hearing complaint
1.5
22.5
803
3959
M01AX17
ATC
nimesulide; oral
1.4
22.5
1393
7673
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
188.8
22.4
26
*
C09CA01
ATC
losartan; oral
1.4
22.3
1425
7885
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
6.2
22.3
64
75
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
67.7
22.1
28
*
SPAT1260
SPAT
Consultation of another employee
1.5
22.1
891
4513
50601
ICD-8 Finland
Chronic laryngitis, Tracheolaryngitis chronica
+∞
22.0
24
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
21.9
783
3862
A11
ICPC
Chest pain NOS
1.8
21.9
406
1674
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
21.8
290
1058
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
21.8
326
1244
D01
ICPC
Abdominal pain/cramps general
1.9
21.8
366
1458
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.6
21.8
171
484
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
21.7
436
1843
R49.03
ICD-10 Finland
Atrophic dysphonia
4.2
21.7
88
153
EBA00
NOMESCO Finland
Extraction of tooth
1.4
21.7
1154
6177
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
21.7
724
3514
R04.2
ICD-10 Finland
Haemoptysis
2.1
21.7
278
999
N01
ICPC
Headache
2.1
21.6
263
925
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.6
21.6
653
3094
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.9
21.6
353
1394
H13
ICPC
Plugged feeling ear
1.4
21.5
1068
5640
U01
ICPC
Dysuria/painful urination
1.9
21.5
333
1287
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
21.5
346
1357
R07
ICPC
Sneezing/nasal congestion
2.9
21.4
136
338
J01MA14
ATC
moxifloxacin; systemic
1.7
21.4
489
2146
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.0
21.3
278
1008
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.7
21.3
514
2295
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.2
21.2
237
804
N17
ICPC
Vertigo/dizziness
1.5
21.0
705
3422
J47
ICD-10 Finland
Bronchiectasis
2.7
21.0
151
407
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
21.0
1734
9990
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.7
21.0
490
2166
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
20.9
696
3373
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.8
20.8
361
1455
N05CF02
ATC
zolpidem; oral
1.6
20.8
656
3140
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
20.8
742
3655
C01DA14
ATC
isosorbide mononitrate; oral
1.3
20.8
2169
12933
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
20.7
917
4728
J01.1
ICD-10 Finland
Acute frontal sinusitis
5.9
20.7
62
77
R01AC02
ATC
levocabastine; nasal
3.6
20.7
99
200
R52.9
ICD-10 Finland
Pain, unspecified
1.8
20.7
367
1488
R51.81
ICD-10 Finland
Facial pain NOS
3.8
20.6
93
179
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.5
20.6
677
3272
Z00.0
ICD-10 Finland
General medical examination
1.5
20.6
911
4700
K03.64
ICD-10 Finland
Dental calculus supragingival
1.6
20.6
564
2605
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.0
20.6
270
981
D06
ICPC
Abdominal pain localized other
2.0
20.5
276
1012
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.5
20.4
837
4252
WZA90
NOMESCO Finland
Other doctors statement
1.6
20.4
657
3161
R12
ICD-10 Finland
Heartburn
2.1
20.3
255
907
B01AC04
ATC
clopidogrel; oral
1.4
20.3
1314
7275
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
20.2
379
1568
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.4
20.2
1201
6549
SDA02
NOMESCO Finland
Parodonthologic therapy
1.5
20.1
857
4383
4720A
ICD-9 Finland
Chronic pharyngitis and nasopharyngitis, Chronic rhinitis[RHINITIS CHRONICA HYPERTROPHICA]
+∞
20.1
22
*
50210
ICD-8 Finland
Chronic pharyngitis and nasopharyngitis, Chronic nasopharyngitis
+∞
20.1
22
*
SPAT1058
SPAT
PEF monitoring instruction
1.9
20.1
331
1310
R06AX12
ATC
terfenadine; oral
2.4
20.0
184
568
R08
ICPC
Nose symptom/complaint other
3.0
20.0
120
288
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
4.1
20.0
83
148
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
5.4
19.9
64
87
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
19.9
1415
7951
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
19.8
2318
14017
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.8
19.8
370
1526
SFA00
NOMESCO Finland
Small filling
1.8
19.8
358
1463
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.4
19.8
175
531
N06AX21
ATC
duloxetine; oral
1.8
19.7
359
1471
J32.8
ICD-10 Finland
Other chronic sinusitis
39.1
19.7
27
5
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
19.5
509
2319
R03AK11
ATC
formoterol and fluticasone; inhalant
3.6
19.5
95
195
H81
ICPC
Excessive ear wax
1.4
19.5
1060
5683
R83
ICPC
Respiratory infection other
1.8
19.3
348
1419
J38.5
ICD-10 Finland
Laryngeal spasm
+∞
19.2
21
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
19.1
2760
17132
R06AX26
ATC
fexofenadine; oral
2.6
19.0
151
430
R53
ICD-10 Finland
Malaise and fatigue
1.3
19.0
1537
8803
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
19.0
666
3264
R01BA01
ATC
phenylpropanolamine; oral
2.3
19.0
191
618
J39.9
ICD-10 Finland
Disease of upper respiratory tract, unspecified
16.0
19.0
33
15
R04.0
ICD-10 Finland
Epistaxis
1.6
18.9
568
2684
R03DC01
ATC
zafirlukast; oral
3.0
18.9
118
291
R01AD
ATC
Corticosteroids
4.6
18.8
69
109
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
18.8
1263
7024
J34.0
ICD-10 Finland
Abscess, furuncle and carbuncle of nose
58.0
18.7
24
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.9
18.7
81
151
ZXC10
NOMESCO Finland
Use of laser
3.3
18.5
100
223
SPAT1053
SPAT
Memory test
1.3
18.5
1405
7965
Z02.4
ICD-10 Finland
Examination for driving licence
1.4
18.5
1148
6297
S82
ICPC
Naevus/mole
1.7
18.5
409
1778
L57.0
ICD-10 Finland
Actinic keratosis
1.5
18.5
816
4202
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
18.5
235
844
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
18.4
1036
5585
SPAT1216
SPAT
Assessment of functional ability
1.4
18.4
1279
7147
M54
ICD-10 Finland
Dorsalgia
1.7
18.4
421
1851
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
18.3
543
2555
J05AB01
ATC
aciclovir; systemic
1.4
18.3
932
4936
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.5
18.2
607
2939
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
18.2
503
2326
R49.0
ICD-10 Finland
Dysphonia
3.9
18.1
78
145
M54.2
ICD-10 Finland
Cervicalgia
2.1
18.0
226
807
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
18.0
493
2272
M02AA10
ATC
ketoprofen; topical
1.4
17.9
854
4462
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
17.9
702
3527
J01EA01
ATC
trimethoprim; systemic
1.3
17.9
1782
10506
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
17.8
998
5371
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.3
17.8
93
203
P20
ICPC
Memory disturbance
1.4
17.7
1263
7082
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
17.6
1318
7447
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
17.6
230
834
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
2.5
17.5
149
444
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
17.5
969
5205
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
17.5
1123
6189
50306
ICD-8 Finland
Chronic sinusitis, Pansinuitis chronica
+∞
17.4
19
*
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
12.6
17.4
33
19
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
3.7
17.3
80
158
C03CA01
ATC
furosemide; systemic
1.3
17.3
3487
22431
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
17.2
369
1590
J01
ICD-10 Finland
Acute sinusitis
3.0
17.2
104
252
L28
ICPC
Limited function/disability (L)
1.3
17.2
1323
7505
H91.1
ICD-10 Finland
Presbycusis
1.5
17.1
717
3649
S22.3
ICD-10 Finland
Fracture of rib
1.7
17.1
383
1673
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.8
17.1
323
1340
A03
ICPC
Fever
1.7
17.0
417
1866
7849C
ICD-9 Finland
Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]
3.8
17.0
76
146
J01FA01
ATC
erythromycin; systemic
1.6
17.0
488
2279
A08
ICPC
Swelling
1.8
16.9
291
1171
M01AB55
ATC
diclofenac, combinations; oral
1.6
16.9
484
2260
A28
ICPC
Limited function/disability NOS
1.3
16.9
1626
9528
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.4
16.8
822
4311
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
16.7
935
5026
H03AA01
ATC
levothyroxine sodium; systemic
1.4
16.7
1120
6211
EMB30
NOMESCO Finland
Adenotomy
25.9
16.7
25
7
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.5
16.7
562
2727
F51.0
ICD-10 Finland
Nonorganic insomnia
1.7
16.4
373
1635
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
16.4
685
3483
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
16.4
324
1364
XG410
NOMESCO Finland
Flow-volume spirometry
2.0
16.4
223
822
J01AA04
ATC
lymecycline; systemic
1.7
16.3
360
1564
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.9
16.3
242
923
L16
ICPC
Ankle symptom/complaint
1.7
16.2
347
1497
A06AC51
ATC
ispaghula, combinations; systemic
1.9
16.2
266
1052
EMA00
NOMESCO Finland
Incision of tonsil
137.6
16.1
19
*
H92.0
ICD-10 Finland
Otalgia
2.3
16.1
158
506
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.6
16.1
457
2129
J01DC02
ATC
cefuroxime; systemic
2.1
16.0
186
642
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
16.0
1517
8856
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
16.0
494
2350
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.3
15.9
160
519
SPAT1097
SPAT
Recording of ECG
1.4
15.9
840
4470
G04BD08
ATC
solifenacin; oral
1.6
15.8
484
2299
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
15.7
349
1521
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
15.6
981
5377
G04CB02
ATC
dutasteride; oral
1.5
15.6
519
2512
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
15.6
903
4883
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
15.5
1631
9657
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.1
15.4
184
643
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.2
15.4
2498
15590
T78.4
ICD-10 Finland
Allergy, unspecified
2.5
15.3
122
350
S12
ICPC
Insect bite/sting
1.8
15.3
300
1258
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
4.1
15.3
63
113
L14
ICPC
Leg/thigh symptom/complaint
1.6
15.2
371
1660
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
15.1
500
2415
E000001
ATC
NA
1.4
15.1
1003
5548
S21
ICPC
Skin texture symptom/complaint
1.5
15.1
530
2596
H93.1
ICD-10 Finland
Tinnitus
2.0
15.0
202
743
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
15.0
488
2348
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
15.0
1153
6528
D12
ICPC
Constipation
1.9
14.9
237
929
K08.80
ICD-10 Finland
Toothache NOS
2.3
14.9
140
441
A01AB10
ATC
natamycin; local oral
1.9
14.9
215
812
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.4
14.8
690
3581
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.6
14.8
457
2170
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
14.8
446
2108
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.7
14.8
324
1408
R03BB01
ATC
ipratropium bromide; inhalant
1.5
14.7
536
2646
AN1
HP
Coronary angiography
1.4
14.7
977
5401
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.5
14.7
545
2701
50303
ICD-8 Finland
Chronic sinusitis, Frontalis NUD
+∞
14.6
16
*
50308
ICD-8 Finland
Chronic sinusitis, Alia definita
+∞
14.6
16
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
14.6
1315
7609
F01
ICPC
Eye pain
2.9
14.6
92
229
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.8
14.6
248
995
J33
ICD-10 Finland
Nasal polyp
14.5
14.6
26
13
A04
ICPC
Weakness/tiredness general
1.4
14.5
911
4992
DHB40
NOMESCO Finland
Conchotomy
36.2
14.5
20
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.3
14.5
1110
6275
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.0
14.4
198
734
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
14.4
414
1934
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.2
14.4
2368
14771
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.0
14.4
185
667
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
2.8
14.4
95
244
J32
ICD-10 Finland
Chronic sinusitis
17.4
14.4
24
10
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.7
14.4
66
131
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.4
14.3
702
3681
J31
ICD-10 Finland
Chronic rhinitis, nasopharyngitis and pharyngitis
6.7
14.3
38
41
D11
ICPC
Diarrhoea
1.6
14.3
350
1568
UJC01
NOMESCO Finland
Scopy of lower throat
3.8
14.2
63
121
R29
ICPC
Respiratory symptom/complaint other
1.9
14.2
216
831
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.8
14.2
94
242
J01AA07
ATC
tetracycline; systemic
1.5
14.2
457
2193
K85
ICPC
Elevated blood pressure
1.4
14.2
835
4525
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
14.1
204
773
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
14.1
386
1782
R49.09
ICD-10 Finland
Unspecified dysphonia
4.3
14.1
55
94
SPAT1254
SPAT
Administration of medicine
1.3
14.1
1147
6539
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.9
14.1
209
798
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
14.1
450
2158
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.8
14.0
266
1107
R05DA01
ATC
ethylmorphine; oral
1.6
14.0
386
1785
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.5
14.0
542
2711
R00.2
ICD-10 Finland
Palpitations
1.9
14.0
208
796
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
13.9
467
2265
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.0
13.9
188
695
G04BD04
ATC
oxybutynin; oral, transdermal
1.5
13.9
510
2524
M01AX01
ATC
nabumetone; oral
1.8
13.9
230
913
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
3.5
13.8
67
139
Z01.7
ICD-10 Finland
Laboratory examination
1.5
13.8
445
2138
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
13.8
674
3534
DFF00
NOMESCO Finland
Pure tone audiometry
1.5
13.7
433
2069
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
13.7
742
3960
XF404
NOMESCO Finland
Ambulatory ECG
1.5
13.7
515
2559
G01AF05
ATC
econazole; vaginal
2.1
13.7
165
581
DPW99
NOMESCO Finland
Other operation on frontal or sphenoidal sinus
34.4
13.7
19
*
B01AF01
ATC
rivaroxaban; oral
1.4
13.6
601
3086
N02AA05
ATC
oxycodone; systemic
1.3
13.6
1163
6678
N03AE01
ATC
clonazepam; systemic
1.8
13.5
258
1075
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
13.5
277
1180
R51
ICD-10 Finland
Headache
2.1
13.5
157
545
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.4
13.5
115
345
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
13.5
229
917
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.4
13.5
620
3211
C08DA01
ATC
verapamil; systemic
1.6
13.5
356
1629
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
13.5
397
1867
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.4
13.4
728
3888
M54.6
ICD-10 Finland
Pain in thoracic spine
1.9
13.4
196
747
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
13.4
408
1933
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.3
13.4
134
434
B01AA03
ATC
warfarin; systemic
1.2
13.3
2280
14253
R06AX18
ATC
acrivastine; oral
2.6
13.3
103
291
H65.2
ICD-10 Finland
Chronic serous otitis media
3.8
13.3
59
114
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.4
13.3
639
3337
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.9
13.2
208
812
D64.9
ICD-10 Finland
Anaemia, unspecified
1.3
13.2
923
5140
M01AC01
ATC
piroxicam; systemic, rectal
1.4
13.2
695
3691
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.9
13.1
211
831
4618A
ICD-9 Finland
Acute sinusitis, Other acute sinusitis
13.4
13.1
24
13
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.7
13.1
301
1326
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
13.1
271
1158
XJH00
NOMESCO Finland
Transanal ultrasonography
1.5
13.1
547
2780
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.2
13.0
2393
15067
D02
ICPC
Abdominal pain epigastric
1.9
13.0
185
698
S16
ICPC
Bruise/contusion
1.9
13.0
193
740
N06AA09
ATC
amitriptyline; systemic
1.5
12.9
501
2508
SPAT1081
SPAT
Cardiorespiratory global assessment
1.6
12.9
362
1681
1210
FHL
Anthroscopy
9.2
12.9
28
22
N30.0
ICD-10 Finland
Acute cystitis
1.3
12.8
880
4885
C10AX09
ATC
ezetimibe; oral
1.6
12.8
370
1730
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.4
12.7
794
4339
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
2.2
12.7
137
460
S01GX09
ATC
olopatadine; ophthalmic
2.7
12.7
89
238
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.5
12.7
461
2275
DMA10
NOMESCO Finland
Exploration of maxillary antrum
41.0
12.7
17
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
12.6
2206
13802
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.8
12.6
244
1021
M05BA04
ATC
alendronic acid; oral
1.4
12.6
743
4023
J39.1
ICD-10 Finland
Other abscess of pharynx
57.9
12.6
16
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.4
12.6
814
4475
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
4.0
12.5
52
95
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.8
12.5
213
858
UJH02
NOMESCO Finland
Anoscopy
2.0
12.5
170
630
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.7
12.4
273
1187
S02CA02
ATC
flumetasone and antiinfectives; otic
1.6
12.4
318
1443
D07AB08
ATC
desonide; topical
1.5
12.3
520
2647
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.5
12.3
395
1896
F29
ICPC
Eye symptom/complaint other
1.7
12.3
283
1248
L02
ICPC
Back symptom/complaint
1.7
12.2
276
1211
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
3.6
12.2
56
112
M15
ICD-10 Finland
Polyarthrosis
1.7
12.2
284
1258
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.8
12.2
203
812
N06AB04
ATC
citalopram; systemic
1.3
12.1
1063
6114
C05AA01
ATC
hydrocortisone; rectal, topical
1.6
12.0
300
1351
N05BA04
ATC
oxazepam; oral
1.3
12.0
1402
8368
H02.3
ICD-10 Finland
Blepharochalasis
1.6
12.0
300
1352
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.5
12.0
489
2472
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.4
12.0
576
3007
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
4.0
11.9
49
89
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
11.9
683
3679
N05BA01
ATC
diazepam; systemic, rectal
1.4
11.9
747
4085
J35.8
ICD-10 Finland
Other chronic diseases of tonsils and adenoids
+∞
11.9
13
*
4738X
ICD-9 Finland
Chronic sinusitis, Other chronic sinusitis
+∞
11.9
13
*
4785A
ICD-9 Finland
Other diseases of upper respiratory tract, Other diseases of vocal cords[NODULAE PLICAE VOCALIS]
+∞
11.9
13
*
4789X
ICD-9 Finland
Other diseases of upper respiratory tract, Other and unspecified diseases of upper respiratory tract
+∞
11.9
13
*
S01
ICPC
Pain/tenderness of skin
1.9
11.8
179
692
R03BC01
ATC
cromoglicic acid; inhalant
4.0
11.8
49
90
R32
ICD-10 Finland
Unspecified urinary incontinence
1.9
11.8
190
749
H02BX01
ATC
methylprednisolone, combinations; systemic
1.5
11.7
414
2029
R06.2
ICD-10 Finland
Wheezing
1.9
11.7
182
708
R39.1
ICD-10 Finland
Other difficulties with micturition
1.9
11.7
173
663
SPAT1360
SPAT
Extensive global examination
1.5
11.7
449
2241
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
11.7
1194
7007
L29
ICPC
Musculoskeletal sympt/complt other
1.6
11.7
318
1466
G04BD07
ATC
tolterodine; oral
1.5
11.7
453
2269
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.0
11.7
145
518
K07
ICPC
Swollen ankles/oedema
1.6
11.6
330
1537
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.6
11.6
288
1296
N04BC05
ATC
pramipexole; oral
1.5
11.6
410
2012
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.0
11.6
151
549
F03
ICPC
Eye discharge
1.9
11.6
177
684
A02BX02
ATC
sucralfate; oral
1.5
11.6
361
1722
H65.3
ICD-10 Finland
Chronic mucoid otitis media
3.1
11.6
66
156
M04AA01
ATC
allopurinol; systemic
1.3
11.6
1108
6448
L60.0
ICD-10 Finland
Ingrowing nail
1.9
11.6
171
655
R11
ICD-10 Finland
Nausea and vomiting
1.4
11.5
497
2540
KCV04
NOMESCO Finland
Distension of bladder with fluid
3.2
11.5
62
141
D07AD01
ATC
clobetasol; topical
1.4
11.5
559
2923
J05AB11
ATC
valaciclovir; oral
1.5
11.5
484
2464
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
17.2
11.5
19
8
J30
ICD-10 Finland
Vasomotor and allergic rhinitis
4.7
11.4
40
62
K07.60
ICD-10 Finland
Snapping jaw
2.9
11.4
71
178
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
11.4
340
1604
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
11.4
419
2074
K59.0
ICD-10 Finland
Constipation
1.5
11.4
427
2121
C10AA04
ATC
fluvastatin; oral
1.4
11.4
725
3974
SPAT1043
SPAT
Audiometry
1.4
11.4
623
3330
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
11.4
456
2298
L04
ICPC
Chest symptom/complaint
1.8
11.4
196
793
K80
ICPC
Cardiac arrhythmia NOS
1.6
11.3
302
1384
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
11.3
457
2308
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.6
11.3
275
1231
R03CC02
ATC
salbutamol; systemic
2.1
11.3
138
491
S04
ICPC
Lump/swelling localized
1.6
11.3
297
1360
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.5
11.3
441
2212
SGA01
NOMESCO Finland
Tooth opening as first aid
1.8
11.3
211
875
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
11.2
456
2305
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
11.2
250
1095
D07XC01
ATC
betamethasone, combinations; topical
1.4
11.2
572
3021
S15
ICPC
Foreign body in skin
1.8
11.2
214
894
F16
ICPC
Eyelid symptom/complaint
1.9
11.2
162
615
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
11.2
529
2755
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
11.2
1150
6754
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.2
11.1
119
400
JN4BD
NOMESCO Finland
Extensive body CT
1.4
11.1
508
2627
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.7
11.1
222
940
B01AF02
ATC
apixaban; oral
1.4
11.1
709
3886
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.8
11.1
188
756
R4130
NOMESCO Finland
Speech therapy
2.2
11.0
116
387
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
11.0
515
2675
A01AC01
ATC
triamcinolone; local oral
2.2
11.0
118
396
G50.1
ICD-10 Finland
Atypical facial pain
3.2
11.0
59
134
J35.3
ICD-10 Finland
Hypertrophy of tonsils with hypertrophy of adenoids
+∞
11.0
12
*
DLD00
NOMESCO Finland
Reconstruction of cartilage of nose
+∞
11.0
12
*
4741A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PALATINAE]
+∞
11.0
12
*
X58
ICD-10 Finland
Exposure to other specified factors
1.5
11.0
412
2049
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.5
11.0
462
2350
R05CB01
ATC
acetylcysteine; inhalant, oral
1.8
11.0
180
717
D07AA02
ATC
hydrocortisone; topical
1.4
11.0
622
3345
207
Kela drug reimbursment
Chronic arrhythmias
1.3
11.0
1237
7345
N05BA12
ATC
alprazolam; oral
1.5
10.9
400
1978
104
Kela drug reimbursment
Thyroid insufficiency
1.5
10.9
384
1883
C07AA05
ATC
propranolol; systemic
1.4
10.9
582
3096
SPAT1057
SPAT
Peak expiratory flow measurement
2.6
10.8
82
232
K05.30
ICD-10 Finland
Periodontitis complex
1.5
10.8
331
1575
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.4
10.7
551
2912
N06AB03
ATC
fluoxetine; oral
1.5
10.7
379
1860
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
10.7
157
601
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.9
10.7
170
668
81
HP
Angiography of the heart and coronary arteries
1.3
10.7
739
4100
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.6
10.7
294
1362
R55
ICD-10 Finland
Syncope and collapse
1.3
10.7
827
4668
P06
ICPC
Sleep disturbance
1.7
10.7
241
1059
1430
FHL
Laryngoscopy (direct)
7.0
10.6
27
28
S76
ICPC
Skin infection other
1.7
10.6
216
921
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.8
10.6
188
768
R09.3
ICD-10 Finland
Abnormal sputum
3.1
10.6
60
141
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
10.6
578
3086
J01MA01
ATC
ofloxacin; systemic
1.4
10.6
617
3332
S01GX02
ATC
levocabastine; ophthalmic
1.8
10.6
171
677
J01MA06
ATC
norfloxacin; oral
1.3
10.6
805
4535
M79.7
ICD-10 Finland
Fibromyalgia
3.1
10.5
59
138
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.5
10.5
316
1497
TQW99
NOMESCO Finland
Other minor procedure on skin
1.6
10.5
310
1462
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
10.5
302
1415
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.6
10.5
314
1485
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
10.4
672
3688
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
10.4
342
1650
H00.1
ICD-10 Finland
Chalazion
2.3
10.4
99
316
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
10.4
248
1106
J02AB02
ATC
ketoconazole; oral
2.4
10.4
88
265
M19.8
ICD-10 Finland
Other specified arthrosis
2.0
10.4
140
521
ENA32
NOMESCO Finland
Incision of deep pharyngeal infection
14.5
10.3
18
9
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.1
10.3
111
377
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.4
10.3
618
3357
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.3
10.2
96
305
M09AX01
ATC
hyaluronic acid; parenteral
1.5
10.2
407
2049
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.6
10.2
261
1186
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.6
10.2
286
1331
UJD02
NOMESCO Finland
Gastroscopy
1.6
10.2
301
1419
K86
ICPC
Hypertension uncomplicated
1.4
10.2
613
3328
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
10.1
216
934
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.4
10.1
490
2561
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.8
10.1
174
704
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
5.8
10.1
29
36
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
10.1
157
614
4783A
ICD-9 Finland
Other diseases of upper respiratory tract, Paralysis of vocal cords or larynx[PARALYSIS PLICAE VOCALIS UNILATERALIS]
+∞
10.1
11
*
4720B
ICD-9 Finland
Chronic pharyngitis and nasopharyngitis, Chronic rhinitis[RHINITIS CHRONICA ATROPHICANS (OZAENA)]
+∞
10.1
11
*
4782A
ICD-9 Finland
Other diseases of upper respiratory tract, Other diseases of pharynx, not elsewhere classified[ABSCESSUS PARAPHARYNGEALIS]
+∞
10.1
11
*
4787A
ICD-9 Finland
Other diseases of upper respiratory tract, Other diseases of larynx, not elsewhere classified
+∞
10.1
11
*
4784B
ICD-9 Finland
Other diseases of upper respiratory tract, Polyp of vocal cord or larynx[GRANULOMA LARYNGIS]
+∞
10.1
11
*
4718X
ICD-9 Finland
Nasal polyps, Other polyp of sinus
+∞
10.1
11
*
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.6
10.0
268
1232
L20.0
ICD-10 Finland
Besnier prurigo
2.1
10.0
111
380
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
10.0
191
799
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
1.4
10.0
448
2310
HMAK
NOMESCO Finland
NA
1.6
10.0
286
1338
D07CC01
ATC
betamethasone and antibiotics; topical
1.4
9.9
521
2764
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
2.4
9.9
83
249
SPAT1059
SPAT
Spirometry at the office
1.7
9.9
216
940
C09AA05
ATC
ramipril; oral
1.2
9.9
1847
11569
R23
ICPC
Voice symptom/complaint
3.0
9.9
58
141
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.6
9.9
282
1316
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.1
9.9
119
422
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
9.9
197
836
J01.4
ICD-10 Finland
Acute pansinusitis
7.0
9.9
25
26
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.7
9.9
214
931
SPAT1036
SPAT
Maxillary puncture
13.0
9.9
18
10
TQW40
NOMESCO Finland
Remowal of suture of skin
1.7
9.9
225
991
R78
ICPC
Acute bronchitis/bronchiolitis
2.3
9.9
88
273
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.5
9.9
325
1571
R81
ICPC
Pneumonia
1.8
9.8
166
667
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
9.8
228
1012
XF600
NOMESCO Finland
Bloodpressure measurement
1.5
9.8
357
1765
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.5
9.8
364
1807
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.7
9.8
209
905
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.4
9.8
619
3389
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
2.6
9.7
73
207
L84
ICPC
Back syndrome without radiat pain
1.8
9.7
162
650
L29.9
ICD-10 Finland
Pruritus, unspecified
2.0
9.7
124
449
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.3
9.7
731
4111
D02AE01
ATC
carbamide; topical
1.6
9.7
252
1152
A06AD11
ATC
lactulose; oral
1.2
9.7
1488
9134
R44
ICPC
Respiratory, Preventive immunization/medic
2.0
9.6
122
443
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.9
9.6
142
546
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.4
9.6
520
2774
A02BD03
ATC
lansoprazole, amoxicillin and metronidazole; systemic
1.4
9.6
437
2260
H60
ICD-10 Finland
Otitis externa
2.0
9.6
115
409
J04.0
ICD-10 Finland
Acute laryngitis
2.6
9.5
68
188
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
9.5
556
3007
S02
ICPC
Pruritus
1.9
9.5
148
579
BAA60
NOMESCO Finland
Total thyroidectomy
2.9
9.4
58
145
P01BA02
ATC
hydroxychloroquine; oral
1.5
9.4
287
1365
A02BDXX
ATC
NA
1.6
9.4
222
990
A46
ICD-10 Finland
Erysipelas
1.3
9.4
873
5050
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.6
9.4
247
1131
ENC30
NOMESCO Finland
Plastic operation of pharynx
5.5
9.3
28
37
LEG10
NOMESCO Finland
Vaginal urethrocystopexy
2.2
9.3
99
333
L11
ICPC
Wrist symptom/complaint
1.6
9.3
234
1060
ENA00
NOMESCO Finland
Internal incision of pharynx
31.3
9.3
13
*
C09DA06
ATC
candesartan and diuretics; oral
1.5
9.3
317
1546
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.1
9.3
110
387
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.7
9.3
183
775
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
3.9
9.3
38
70
M77.4
ICD-10 Finland
Metatarsalgia
1.9
9.3
127
475
M05BX04
ATC
denosumab; parenteral
1.5
9.3
312
1515
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.7
9.2
178
750
4785B
ICD-9 Finland
Other diseases of upper respiratory tract, Other diseases of vocal cords[LEUKOPLAKIA PLICAE VOCALIS]
+∞
9.2
10
*
4742A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Adenoid vegetations
+∞
9.2
10
*
4731A
ICD-9 Finland
Chronic sinusitis, Frontal
+∞
9.2
10
*
4750A
ICD-9 Finland
Peritonsillar abscess[PERITONSILLITIS DIFFUSA]
+∞
9.2
10
*
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.7
9.1
200
874
L43.9
ICD-10 Finland
Lichen planus, unspecified
2.5
9.1
71
205
S22
ICPC
Nail symptom/complaint
1.6
9.1
233
1061
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.3
9.1
778
4452
I49.1
ICD-10 Finland
Atrial premature depolarization
1.9
9.1
137
530
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
1.7
9.1
177
746
A01
ICPC
Pain general/multiple sites
1.4
9.1
393
2014
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
1.7
9.1
189
813
H61.2
ICD-10 Finland
Impacted cerumen
1.5
9.1
295
1424
M75
ICD-10 Finland
Shoulder lesions
1.8
9.0
152
612
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.5
9.0
318
1563
M10
ICD-10 Finland
Gout
1.6
9.0
231
1053
N02AC04
ATC
dextropropoxyphene; oral
1.4
9.0
380
1938
R01AC07
ATC
nedocromil; nasal
6.0
9.0
25
30
DMW00
NOMESCO Finland
Intubation of maxillary antrum
20.3
9.0
14
5
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.5
9.0
290
1396
G04BD11
ATC
fesoterodine; oral
1.7
9.0
202
889
KED22
NOMESCO Finland
Transurethral resection of prostate
1.3
9.0
575
3154
G03CA04
ATC
estriol; systemic, vaginal
1.3
9.0
659
3689
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.9
9.0
55
137
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
2.3
8.9
82
259
L05
ICPC
Flank/axilla symptom/complaint
1.6
8.9
214
956
C10AA03
ATC
pravastatin; oral
1.4
8.9
489
2615
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
8.9
201
886
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
2.0
8.9
116
427
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.9
8.9
126
479
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.2
8.9
1084
6486
A97
ICPC
No disease
1.3
8.9
597
3301
G01AF01
ATC
metronidazole; vaginal
1.7
8.8
177
754
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
8.8
307
1504
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.3
8.8
645
3612
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.5
8.8
268
1273
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.6
8.8
244
1136
S06
ICPC
Rash localized
1.6
8.8
242
1123
A02BA03
ATC
famotidine; systemic
1.5
8.7
330
1646
K02.0
ICD-10 Finland
Caries limited to enamel
1.7
8.7
179
767
N05CD07
ATC
temazepam; oral
1.2
8.7
1132
6817
7860A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]
2.3
8.7
78
244
L30.0
ICD-10 Finland
Nummular dermatitis
1.8
8.7
138
546
N07CA01
ATC
betahistine; oral
1.4
8.7
451
2390
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
2.4
8.7
71
211
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
1.5
8.6
283
1370
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.2
8.6
1398
8617
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.6
8.6
39
79
F05
ICPC
Visual disturbance other
2.0
8.6
114
423
L20
ICPC
Joint symptom/complaint NOS
2.0
8.6
109
395
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.5
8.6
297
1455
WZC30
NOMESCO Finland
Teaching
1.4
8.6
359
1827
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.8
8.6
135
533
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.8
8.5
155
641
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.3
8.5
845
4925
H66.9
ICD-10 Finland
Otitis media, unspecified
1.9
8.5
125
480
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.4
8.5
415
2173
H57.1
ICD-10 Finland
Ocular pain
2.2
8.5
86
285
S01KA02
ATC
hypromellose; ophthalmic
2.0
8.5
108
393
Z00.8
ICD-10 Finland
Other general examinations
1.5
8.5
260
1240
K08.3
ICD-10 Finland
Retained dental root
1.5
8.4
283
1377
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
3.2
8.4
44
100
K12.00
ICD-10 Finland
Recurrent oral aphthae
3.6
8.4
38
77
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
1.8
8.4
148
605
7862A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Cough
2.7
8.4
56
148
N05BB01
ATC
hydroxyzine; systemic
1.4
8.4
341
1726
R06AX11
ATC
astemizole; oral
2.1
8.4
90
306
49099
ICD-8 Finland
Bronchitis, unspecified
2.5
8.4
66
192
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
8.4
208
941
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.5
8.3
269
1297
I50.9
ICD-10 Finland
Heart failure, unspecified
1.2
8.3
1804
11426
M54.3
ICD-10 Finland
Sciatica
1.6
8.3
203
913
D06BB03
ATC
aciclovir; topical
1.8
8.3
151
623
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.6
8.3
236
1105
L86
ICPC
Back syndrome with radiating pain
1.7
8.3
185
814
SPAT1211
SPAT
Application of soft bandage
1.4
8.3
437
2323
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
3.4
8.2
40
86
50702
ICD-8 Finland
Hay fever, Aestivalis
+∞
8.2
9
*
50309
ICD-8 Finland
Chronic sinusitis, Unspecified
+∞
8.2
9
*
50800
ICD-8 Finland
Other diseases of upper respiratory tract, Abscessus laryngis
+∞
8.2
9
*
50700
ICD-8 Finland
NA
+∞
8.2
9
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.7
8.2
166
710
L90
ICPC
Osteoarthrosis of knee
1.5
8.2
251
1195
R60.9
ICD-10 Finland
Oedema, unspecified
1.5
8.2
251
1198
D06BX01
ATC
metronidazole; topical
1.5
8.2
327
1651
A05
ICPC
Feeling ill
1.7
8.2
177
772
WX110
SPAT
NA
2.2
8.2
81
265
J01CA08
ATC
pivmecillinam; oral
1.2
8.2
1975
12629
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
2.6
8.2
59
165
S08
ICPC
Skin colour change
1.6
8.1
220
1017
L95
ICPC
Osteoporosis
1.7
8.1
175
761
L04AX01
ATC
azathioprine; systemic
1.9
8.1
126
496
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
1.8
8.1
144
592
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
1.7
8.1
170
736
A07EC01
ATC
sulfasalazine; oral, rectal
1.5
8.1
288
1420
D06BB10
ATC
imiquimod; topical
1.6
8.1
218
1008
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.4
8.1
70
214
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.4
8.1
341
1739
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.5
8.1
283
1390
M01AH03
ATC
valdecoxib; oral
1.6
8.1
219
1014
R05CB02
ATC
bromhexine; systemic
1.8
8.0
147
610
I20.09
ICD-10 Finland
Unstable angina
1.4
8.0
491
2673
G01AF04
ATC
miconazole; vaginal
2.0
8.0
101
368
WVA20
NOMESCO Finland
Medicine administration
2.1
8.0
90
313
PHD99
NOMESCO Finland
Resection of other vein
1.7
8.0
172
747
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.3
8.0
70
217
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.5
8.0
308
1545
M43.1
ICD-10 Finland
Spondylolisthesis
1.9
8.0
124
486
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.8
8.0
130
520
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
8.0
190
852
D04
ICPC
Rectal/anal pain
2.6
8.0
58
163
C01CA24
ATC
epinephrine; parenteral
2.2
8.0
82
273
H25.8
ICD-10 Finland
Other senile cataract
1.2
8.0
1060
6398
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.3
7.9
690
3955
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.4
7.9
69
212
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
1.9
7.9
108
405
C08CA13
ATC
lercanidipine; oral
1.3
7.9
786
4584
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
2.3
7.9
70
219
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.9
7.9
112
427
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
7.9
535
2962
K03.00
ICD-10 Finland
Approximal wear
2.2
7.8
82
277
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
1.7
7.8
145
604
H02.4
ICD-10 Finland
Ptosis of eyelid
1.8
7.8
125
496
UJC02
NOMESCO Finland
Rigid oesophagoscopy
2.9
7.8
47
118
N06AB06
ATC
sertraline; oral
1.5
7.8
257
1245
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.2
7.8
76
247
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.1
7.8
88
306
ZX120
NOMESCO Finland
Intravenous
1.4
7.8
435
2336
L09
ICPC
Arm symptom/complaint
1.8
7.8
141
585
P01
ICPC
Feeling anxious/nervous/tense
1.9
7.7
115
446
G03FB05
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.6
7.7
208
961
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.2
7.7
1290
7966
M01AG01
ATC
mefenamic acid; oral
2.1
7.7
90
318
D01AC02
ATC
miconazole; topical
1.3
7.7
496
2722
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.7
7.7
161
696
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
7.7
131
530
I45.9
ICD-10 Finland
Conduction disorder, unspecified
2.1
7.7
85
293
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
1.5
7.7
254
1233
WX722
NOMESCO Finland
PEEP
1.6
7.7
212
988
K03.0
ICD-10 Finland
Excessive attrition of teeth
2.4
7.7
63
190
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
1.8
7.7
133
544
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.7
7.7
147
620
SPAT1257
SPAT
Teaching of medicine inhalation technique
1.6
7.7
174
771
K92.1
ICD-10 Finland
Melaena
1.4
7.7
407
2168
-60
ICPC
Result test/procedure
1.5
7.7
288
1435
E000002
ATC
NA
1.4
7.6
412
2200
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.5
7.6
255
1242
62660
ICD-8 Finland
Disorders of menstruation, Intermenstrual bleeding
1.6
7.6
199
913
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
1.6
7.6
175
776
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.7
7.6
155
665
SPAT1210
SPAT
Application of cast or individual aid
1.8
7.6
141
587
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.3
7.6
68
214
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
7.6
948
5680
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.3
7.6
472
2577
R19.5
ICD-10 Finland
Other faecal abnormalities
2.4
7.6
64
194
H25.0
ICD-10 Finland
Senile incipient cataract
1.4
7.5
429
2311
R15
ICD-10 Finland
Faecal incontinence
1.7
7.5
144
606
M10.9
ICD-10 Finland
Gout, unspecified
1.4
7.5
396
2105
-69
ICPC
Other reason for encounter NEC
1.6
7.5
204
945
I50
ICD-10 Finland
Heart failure
1.4
7.5
358
1868
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
3.3
7.5
37
81
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.7
7.5
154
662
S01GX04
ATC
nedocromil; ophthalmic
2.4
7.5
61
182
K01
ICPC
Heart pain
2.0
7.5
90
321
N06AB10
ATC
escitalopram; oral
1.3
7.5
559
3140
SPAT1229
SPAT
Assessment of need for aid
1.3
7.5
607
3446
A13
ICPC
Concern/fear medical treatment
2.1
7.5
86
303
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.4
7.5
301
1523
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
1.6
7.4
200
926
I20.00
ICD-10 Finland
Unstable angina
1.4
7.4
320
1639
GD1AD
NOMESCO Finland
Thorax CT examination
1.7
7.4
155
671
ENC40
NOMESCO Finland
Uvulopalatopharyngoplasty
4.5
7.4
26
42
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
1.5
7.4
227
1082
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.3
7.4
807
4760
H10
ICD-10 Finland
Conjunctivitis
1.8
7.4
134
556
R31
ICD-10 Finland
Unspecified haematuria
1.3
7.4
733
4274
G03CB01
ATC
dienestrol; oral, vaginal
1.5
7.4
286
1435
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.9
7.4
112
439
A03DA02
ATC
pitofenone and analgesics; systemic
1.7
7.4
164
721
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.7
7.4
149
638
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.4
7.3
440
2388
C09CA07
ATC
telmisartan; oral
1.4
7.3
294
1486
K57
ICD-10 Finland
Diverticular disease of intestine
2.0
7.3
89
319
T90
ICPC
Diabetes non-insulin dependent
1.2
7.3
1065
6486
R19.4
ICD-10 Finland
Change in bowel habit
2.0
7.3
95
350
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.4
7.3
356
1867
RF210
NOMESCO Finland
NA
1.9
7.3
103
393
R50.9
ICD-10 Finland
Fever, unspecified
1.3
7.2
705
4099
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
1.7
7.2
163
720
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
1.8
7.2
131
544
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
6.9
7.2
18
19
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
7.2
274
1371
K78
ICPC
Atrial fibrillation/flutter
1.3
7.2
649
3742
4227
FHL
Forehead cavity drainage
19.9
7.1
11
*
N03AF01
ATC
carbamazepine; oral, rectal
1.4
7.1
308
1582
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.5
7.1
250
1229
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
1.8
7.1
121
493
J01CA02
ATC
pivampicillin; oral
1.9
7.1
106
413
6256A
ICD-9 Finland
Pain and other symptoms associated with female genital organs, Stress incontinence, female
2.1
7.1
76
258
TDA90
NOMESCO Finland
Removal wax from ear
2.1
7.1
83
294
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.6
7.1
168
753
N30
ICD-10 Finland
Cystitis
1.4
7.1
321
1664
M70.7
ICD-10 Finland
Other bursitis of hip
1.8
7.1
115
462
XA420
NOMESCO Finland
Extensive sleep examination
3.5
7.1
32
66
Z02.7
ICD-10 Finland
Issue of medical certificate
1.4
7.0
308
1585
W10
ICD-10 Finland
Fall on and from stairs and steps
1.5
7.0
227
1096
Z97.8
ICD-10 Finland
Presence of other specified devices
2.8
7.0
45
118
H02AB09
ATC
hydrocortisone; systemic
2.2
7.0
73
246
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
7.0
207
980
L72.1
ICD-10 Finland
Trichilemmal cyst
1.6
7.0
186
861
K03.66
ICD-10 Finland
Tooth plaque
1.6
7.0
175
798
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.4
7.0
365
1940
S51.0
ICD-10 Finland
Open wound of elbow
2.1
7.0
75
256
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
2.3
7.0
61
191
D01AC07
ATC
tioconazole; topical
1.5
7.0
235
1148
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.2
6.9
777
4598
H01.0
ICD-10 Finland
Blepharitis
1.7
6.9
145
629
R05CB03
ATC
carbocisteine; oral
1.6
6.9
163
731
EB1AA
SPAT
NA
2.0
6.9
84
304
M10.0
ICD-10 Finland
Idiopathic gout
1.6
6.9
185
858
4471
FHL
Pharyngoplasty
3.6
6.9
30
60
K40
ICD-10 Finland
Inguinal hernia
1.9
6.9
102
397
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.6
6.9
188
876
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.4
6.9
278
1411
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.4
6.8
359
1910
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
1.9
6.8
98
378
TPH07
NOMESCO Finland
Cathetrisation of artery
1.3
6.8
510
2866
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.4
6.8
298
1533
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.6
6.8
165
744
WZA00
NOMESCO Finland
Short statement of of health and health related matters
1.7
6.8
134
572
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
2.0
6.8
89
329
N06AA12
ATC
doxepin; systemic
1.4
6.8
277
1405
JN4AD
NOMESCO Finland
Body CT examination
1.4
6.8
284
1450
I83
ICD-10 Finland
Varicose veins of lower extremities
2.0
6.8
81
291
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.2
6.8
65
213
1340
FHL
Hypopharyngoscopy
5.7
6.8
19
24
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
2.1
6.7
71
240
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.4
6.7
269
1360
SPAT1104
SPAT
Monitoring of emergency patient
1.4
6.7
340
1797
J05.1
ICD-10 Finland
Acute epiglottitis
7.2
6.7
16
16
XX3DW
NOMESCO Finland
Time consuming IT work
1.4
6.7
306
1588
R68.2
ICD-10 Finland
Dry mouth, unspecified
3.0
6.7
38
92
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.6
6.7
181
840
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
15.9
6.7
11
5
WX892
NOMESCO Finland
Monitored bed care
1.4
6.6
372
1999
F45.8
ICD-10 Finland
Other somatoform disorders
2.2
6.6
66
219
G50.0
ICD-10 Finland
Trigeminal neuralgia
2.3
6.6
63
203
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.5
6.6
231
1135
DAX08
NOMESCO Finland
Fitting of hearing aid
1.4
6.6
302
1566
H81.3
ICD-10 Finland
Other peripheral vertigo
1.7
6.6
127
539
4451
FHL
Guitar cutting
32.5
6.6
9
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.3
6.6
432
2382
S19
ICPC
Skin injury other
1.6
6.6
189
889
GD1AA
SPAT
NA
2.0
6.6
79
283
M76.0
ICD-10 Finland
Gluteal tendinitis
2.6
6.6
47
133
H65.0
ICD-10 Finland
Acute serous otitis media
3.0
6.6
37
89
U04
ICPC
Incontinence urine
1.4
6.5
323
1701
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.5
6.5
254
1277
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.4
6.5
320
1683
M01AB01
ATC
indometacin; systemic, rectal
1.3
6.5
575
3304
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.4
6.5
383
2074
U71
ICPC
Cystitis/urinary infection other
1.4
6.5
258
1302
78329
ICD-8 Finland
Symptoms referable to respiratory system, Dyspnoea alia sive NUD
2.7
6.5
43
116
Z50.5
ICD-10 Finland
Speech therapy
2.3
6.5
57
177
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.5
6.5
194
922
4900A
ICD-9 Finland
Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]
2.5
6.4
49
143
U07
ICPC
Urine symptom/complaint other
1.4
6.4
278
1428
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.6
6.4
169
779
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.4
6.4
286
1478
A29
ICPC
General symptom/complaint other
1.3
6.4
612
3552
J39.3
ICD-10 Finland
Upper respiratory tract hypersensitivity reaction, site unspecified
57.9
6.4
8
*
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
2.3
6.4
57
180
4739X
ICD-9 Finland
Chronic sinusitis, Unspecified sinusitis (chronic)
+∞
6.4
7
*
50000
ICD-8 Finland
NA
+∞
6.4
7
*
50200
ICD-8 Finland
Chronic pharyngitis and nasopharyngitis, Chronic pharyngitis
+∞
6.4
7
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.5
6.4
184
867
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
1.8
6.4
109
445
G01AF02
ATC
clotrimazole; vaginal
2.3
6.4
59
189
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
1.9
6.4
96
377
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.9
6.4
96
377
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.6
6.4
143
634
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
4.3
6.4
23
39
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
1.8
6.4
105
424
56500
ICD-8 Finland
Anal fissure and fistula, Anal fissure
2.0
6.4
80
294
M95.0
ICD-10 Finland
Acquired deformity of nose
18.1
6.4
10
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.2
6.3
747
4444
K03.11
ICD-10 Finland
Abrasion dentifrice of teeth
2.7
6.3
41
109
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.5
6.3
207
1008
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
6.3
103
416
A02BD02
ATC
lansoprazole, tetracycline and metronidazole; systemic
1.8
6.3
103
416
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
2.2
6.3
61
200
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.5
6.3
237
1187
4509
FHL
Other measure in this category
13.3
6.3
11
6
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.3
6.3
530
3029
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.6
6.3
145
646
-
ICD-10 Finland
NA
1.7
6.3
122
520
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
2.3
6.3
54
169
S10
ICPC
Boil/carbuncle
1.6
6.2
145
649
S02.52
ICD-10 Finland
Tooth fracture to pulp
2.8
6.2
38
98
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
6.2
127
549
WF002
NOMESCO Finland
Radical radiotherapy
1.7
6.2
135
593
U72
ICPC
Urethritis
1.9
6.2
87
333
I84.5
ICD-10 Finland
External hemorrhoids without complication
1.8
6.2
98
389
4939A
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]
3.4
6.2
29
62
SXC05
NOMESCO Finland
Other oral or dental procedure
1.8
6.2
98
390
R01AD04
ATC
flunisolide; nasal
2.9
6.2
37
94
R05DB20
ATC
other cough suppressants - combinations
1.4
6.2
265
1359
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.2
6.2
785
4707
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
1.5
6.2
227
1128
K96
ICPC
Haemorrhoids
2.1
6.2
70
247
M18.0
ICD-10 Finland
Primary arthrosis of first carpometacarpal joints, bilateral
3.0
6.2
35
85
-44
ICPC
Preventive immunization/medic
1.3
6.2
445
2490
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
1.8
6.2
105
429
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.4
6.1
325
1732
S01GX08
ATC
ketotifen; ophthalmic
2.0
6.1
78
288
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.0
6.1
78
288
XG466
NOMESCO Finland
Sleep oxymetry
1.7
6.1
119
507
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
1.5
6.1
206
1007
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.7
6.1
122
522
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.3
6.1
613
3577
M70.2
ICD-10 Finland
Olecranon bursitis
1.8
6.1
108
445
H84
ICPC
Presbyacusis
1.4
6.1
287
1500
R52.2
ICD-10 Finland
Other chronic pain
1.7
6.1
112
470
XKC03
NOMESCO Finland
Water cystometry
1.7
6.1
129
564
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.6
6.1
140
623
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.8
6.1
103
421
H10.4
ICD-10 Finland
Chronic conjunctivitis
3.2
6.1
30
67
E000007
ATC
NA
1.5
6.1
173
815
45599
ICD-8 Finland
Haemorrhoids
1.4
6.1
273
1414
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
1.7
6.1
113
473
R30.1
ICD-10 Finland
Vesical tenesmus
2.0
6.1
78
290
R2110
NOMESCO Finland
Giving the first information
1.5
6.0
208
1021
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
2.4
6.0
49
148
DPA20
NOMESCO Finland
Trephine of frontal sinus
21.7
6.0
9
*
M77.1
ICD-10 Finland
Lateral epicondylitis
2.2
6.0
57
186
L76
ICPC
Fracture: other
1.6
6.0
166
775
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
2.1
6.0
66
229

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
10463
36531
1.57
322.26
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
14869
56403
1.47
310.28
1.5
1.4
g/l
2.3
2.4
8.58
9021
34486
(3007853) Bacteria identified in Skin by Aerobe culture
9481
32652
1.59
308.06
1.8
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
24561
98107
1.46
307.65
6.1
6.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
64380
304008
1.83
307.65
15.3
13.2
mg/l
22.2
24.0
33.39
52102
237581
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
12285
44354
1.53
307.65
1.3
1.2
u/ml
11.0
11.8
0.44
4628
17440
(3019198) Lymphocytes [#/volume] in Blood
36328
149726
1.52
307.65
6.1
5.9
e9/l
2.0
1.9
1.81
32289
131653
(3010726) Horse dander IgE Ab [Units/volume] in Serum
2054
3849
2.83
307.65
1.1
1.0
u/ml
2.4
2.3
0.07
594
871
(3023103) Potassium [Moles/volume] in Serum or Plasma
63885
308318
1.61
307.65
17.0
15.3
mmol/l
4.0
4.0
11.89
62380
299330
(3018010) Neutrophils/100 leukocytes in Blood
33816
139356
1.49
307.65
6.1
5.9
%
56.7
57.3
17.12
31672
130567
(3019550) Sodium [Moles/volume] in Serum or Plasma
63751
307429
1.60
307.65
16.9
15.2
mmol/l
139.6
139.6
1.52
62350
299046
(3005322) IgE [Units/volume] in Serum or Plasma
6585
15031
2.41
307.65
1.4
1.2
u/ml
270.7
226.2
1.42
6142
13814
(4010399)
6299
17861
1.92
307.65
1.5
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
2399
4684
2.73
307.65
1.2
1.1
u/ml
1.8
1.7
0.16
1172
1678
(3022096) Basophils/100 leukocytes in Blood
32212
132252
1.48
307.65
6.3
6.1
%
0.7
0.7
8.57
30074
123410
(3001604) Monocytes [#/volume] in Blood
35340
144826
1.52
307.65
6.1
5.9
e9/l
0.6
0.6
1.22
30812
125091
(3006504) Eosinophils/100 leukocytes in Blood
33161
136436
1.49
307.65
6.3
6.0
%
3.1
2.8
71.61
30961
127249
(40768804) Tissue Pathology biopsy report
27554
115819
1.38
307.65
2.1
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
15208
56627
1.50
307.65
1.7
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
2158
4147
2.76
307.65
1.1
1.0
u/ml
6.3
5.0
2.15
1298
1874
(3013707) Erythrocyte sedimentation rate by Westergren method
49527
216049
1.60
307.65
4.5
3.8
mm/h
11.1
12.0
38.70
46223
199723
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
49668
224999
1.46
307.65
7.7
7.3
u/l
76.3
78.8
24.35
46862
211638
(3020564) Creatinine [Moles/volume] in Serum or Plasma
65962
322416
1.64
307.65
17.0
15.2
umol/l
76.4
76.9
3.39
65943
322232
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
45142
204392
1.39
307.65
3.4
3.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
43575
196171
1.39
307.65
4.8
4.2
e6/l
1069.1
1417.8
0.67
584
2814
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
13039
47378
1.53
307.65
1.3
1.3
iu/ml
31.1
37.5
1.66
3938
14788
(3037467) Urinalysis macro (dipstick) panel - Urine
45423
205781
1.39
307.65
4.6
4.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
33372
137164
1.49
307.65
6.6
6.3
%
8.5
8.6
5.61
31288
128590
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
50555
229767
1.47
307.65
4.3
3.8
pmol/l
14.7
14.7
0.19
46259
209058
(40761511) CBC panel - Blood by Automated count
65362
318948
1.61
307.65
14.0
12.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
58912
275418
1.58
307.65
5.2
4.5
mu/l
2.0
2.1
0.79
54543
253230
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
66266
323823
1.67
307.65
10.9
9.7
u/l
26.8
26.4
4.38
64238
312311
(3002030) Lymphocytes/100 leukocytes in Blood
34247
141617
1.49
307.65
6.4
6.1
%
28.4
28.1
6.84
31961
132095
(3013115) Eosinophils [#/volume] in Blood
36726
150075
1.55
307.65
6.3
6.1
e9/l
0.2
0.2
68.01
32507
131490
(3006315) Basophils [#/volume] in Blood
35486
145540
1.52
307.65
6.1
5.9
e9/l
0.0
0.0
8.78
30950
125675
(3000492) Spirometry study
8046
25864
1.70
307.65
1.5
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
39703
168912
1.49
307.65
8.7
9.1
e9/l
4.1
4.1
4.82
34787
147255
(3007461) Platelets [#/volume] in Blood
69154
343352
1.82
304.43
22.3
19.3
e9/l
253.7
251.8
11.42
67733
333792
(3035941) MCH [Entitic mass]
69187
343651
1.82
301.94
22.2
19.2
pg
30.3
30.2
2.68
68450
338527
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
59668
286436
1.45
301.71
4.6
4.2
mmol/l
5.9
5.9
3.19
54907
262466
(3026361) Erythrocytes [#/volume] in Blood
69198
343731
1.82
301.69
22.3
19.3
e12/l
4.5
4.5
17.53
67594
333157
(3024731) MCV [Entitic volume]
69189
343699
1.82
300.92
22.2
19.3
fl
90.7
90.7
0.87
68448
338565
(3010813) Leukocytes [#/volume] in Blood
69206
343814
1.82
300.78
22.3
19.4
e9/l
6.8
6.7
11.34
67628
333230
(3000963) Hemoglobin [Mass/volume] in Blood
69208
343858
1.82
299.87
22.4
19.4
g/l
136.1
135.4
24.39
68474
338762
(3008401) Mugwort IgE Ab [Units/volume] in Serum
2030
4035
2.67
299.84
1.1
1.0
u/ml
1.1
1.1
0.15
1062
1469
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
56473
268763
1.41
293.23
5.8
5.4
mmol/mol
39.4
39.5
1.71
52577
249293
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
27809
118638
1.36
291.94
2.4
2.2
nmol/l
77.2
841.3
0.50
25154
107161
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
34021
149821
1.34
289.05
5.9
6.1
umol/l
11.1
11.6
7.89
32167
141593
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
15941
62155
1.43
283.95
1.8
1.8
mg/l
1.1
1.3
10.18
11972
47265
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
16653
65558
1.42
280.82
1.3
1.3
u/ml
1.6
1.8
1.07
4201
18041
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
44109
202484
1.34
278.26
3.2
3.0
u/l
46.8
46.9
0.11
41365
189730
(3013826) Glucose [Moles/volume] in Serum or Plasma
38161
171488
1.33
278.23
4.9
4.7
mmol/l
6.6
6.7
24.64
35654
158902
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
972
1257
4.07
273.86
1.4
1.3
u/ml
1.0
1.6
1.01
487
485
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
32259
141645
1.33
273.71
6.9
6.7
mmol/l
1.2
1.2
4.47
27625
118774
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
58471
281018
1.41
271.44
13.5
12.4
ml/min/173m2
84.0
83.1
17.03
48604
229577
(3048689) Calprotectin [Mass/mass] in Stool
9901
35430
1.53
268.85
2.4
2.4
ug/g
121.6
138.7
3.77
7728
27880
(3037522) Nuclear Ab [Titer] in Serum
10489
38044
1.51
267.40
1.4
1.3
titre
507.9
556.0
1.58
2074
7628
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
61699
299682
1.45
266.70
4.9
4.5
mmol/l
2.8
2.8
0.67
57299
277272
(3001122) Ferritin [Mass/volume] in Serum or Plasma
30258
132049
1.33
264.31
3.0
2.8
ug/l
116.2
122.0
2.39
28163
122560
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
60370
292237
1.43
262.41
4.4
4.1
mmol/l
1.4
1.5
11.22
56096
270860
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
60770
294666
1.43
259.44
4.5
4.1
mmol/l
4.6
4.7
2.74
56750
274265
(3000494) Fungus identified in Specimen by Culture
8966
31631
1.54
258.71
1.6
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
29385
128090
1.33
255.87
6.3
6.1
mmol/l
1.2
1.2
5.64
26709
116033
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
58456
281977
1.39
249.74
4.0
3.7
mmol/l
1.3
1.3
10.48
54025
260015
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
26663
115262
1.32
241.48
2.0
1.9
pmol/l
97.9
95.3
13.98
13945
61083
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
20233
84458
1.34
229.66
2.2
2.1
u/l
181.7
224.8
7.97
19010
79173
(3014133) Dog dander IgE Ab [Units/volume] in Serum
1659
3418
2.57
228.37
1.1
1.0
u/ml
5.2
3.9
1.31
766
1211
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
21495
90690
1.33
226.29
2.6
2.5
u/l
57.0
58.8
3.00
19840
83605
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
24494
106187
1.30
208.03
3.7
3.5
ng/l
71.6
63.3
0.14
15593
70281
(3042936) Bacteria identified in Isolate by Culture
10370
39278
1.44
207.26
2.1
2.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
1537
3210
2.53
205.87
1.1
1.0
u/ml
5.8
5.2
0.44
750
1217
(3024561) Albumin [Mass/volume] in Serum or Plasma
28049
123993
1.29
204.50
4.8
4.8
g/l
35.9
35.5
29.31
25950
114975
(3026493) Urate [Moles/volume] in Serum or Plasma
17821
74544
1.33
192.11
2.7
2.6
umol/l
3089.8
4705.9
7.13
15408
65004
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
1313
2792
2.48
169.50
1.1
1.0
u/ml
0.4
0.5
0.13
391
460
(3044889) 12 lead EKG panel
42963
202784
1.25
166.15
3.9
3.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
5852
20588
1.52
166.02
2.8
2.6
g/l
10.3
10.7
7.96
5409
18781
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
30822
140146
1.25
165.69
4.1
4.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
6961
25425
1.47
164.88
2.2
2.2
nmol/l
362.5
380.9
10.97
6386
23465
(3009542) Hematocrit [Volume Fraction] of Blood
58155
284849
1.31
164.73
16.1
14.1
%
40.2
39.8
20.88
43504
210147
(3015377) Calcium [Moles/volume] in Serum or Plasma
21829
95402
1.27
163.29
3.2
3.4
mmol/l
2.4
2.4
0.73
18888
83654
(3023419) Bacteria identified in Sputum by Culture
1245
2681
2.45
156.60
3.1
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
11223
45097
1.35
153.22
1.9
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6332
23191
1.46
146.89
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
17193
73745
1.28
145.82
6.7
7.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
25518
114743
1.24
144.82
8.6
8.8
inr
1.2
1.2
3.53
7015
34299
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16360
69835
1.28
143.74
2.4
2.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
21072
92774
1.26
143.64
2.4
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
23386
104269
1.25
142.52
3.9
3.6
e6/l
66.8
105.5
11.98
16530
73015
(3022145) Colonoscopy Study observation
8061
31026
1.40
142.42
1.3
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
17776
76752
1.27
142.28
3.0
3.0
ng/l
1228.8
1509.1
12.74
14981
65487
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
2547
7533
1.79
140.85
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
2405
6990
1.82
140.70
1.2
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
12958
53756
1.31
140.66
3.9
3.6
ng/l
371.7
551.3
4.56
9518
40674
(3024980) IgG subclass 4 [Mass/volume] in Serum
1595
4025
2.09
139.43
1.6
1.6
g/l
0.8
0.8
0.17
1234
2987
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
5246
18691
1.50
139.08
2.4
2.3
au/ml
26.5
23.6
0.75
299
1089
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
16959
72969
1.28
139.01
2.3
2.2
mg/l
2.8
3.0
7.81
14486
62285
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
4850
17003
1.52
138.71
1.3
1.3
au/ml
44.9
49.8
0.66
182
723
(3019225) pH of Specimen
6964
26314
1.42
136.21
4.3
4.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
31887
147487
1.22
135.84
3.7
3.5
estimate
0.0
0.0
0.15
5559
28285
(3028192) IgG subclass 2 [Mass/volume] in Serum
1103
2404
2.41
135.28
1.4
1.3
g/l
2.9
3.0
1.79
806
1597
(3021601) Nitrite [Presence] in Urine by Test strip
31936
147793
1.22
135.02
5.1
4.7
estimate
0.0
0.0
0.10
5740
28975
(3024139) IgG subclass 3 [Mass/volume] in Serum
1101
2404
2.41
134.52
1.4
1.3
g/l
0.4
0.4
2.55
806
1603
(4062490)
1101
2407
2.41
134.17
1.4
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
21839
97131
1.24
133.84
3.2
3.2
u/l
33.1
33.7
0.37
20691
92012
(3027135) IgG subclass 1 [Mass/volume] in Serum
1101
2411
2.40
133.70
1.4
1.3
g/l
6.4
7.0
6.35
804
1603
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
8383
32800
1.38
133.59
4.5
4.3
%
32.0
32.4
2.08
5924
22600
(3009261) Glucose [Presence] in Urine by Test strip
32226
149380
1.22
133.47
3.8
3.5
estimate
0.0
0.0
0.43
5568
28176
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
586
908
3.38
130.06
1.1
1.0
u/ml
8.9
9.4
0.09
124
119
(3015736) pH of Urine
25272
114518
1.23
128.95
3.5
3.3
ph
5.8
5.8
0.00
22
76
(36304419) Bacteria [Presence] in Urine
18061
78907
1.26
128.28
3.2
3.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
4520
16004
1.50
122.85
1.9
1.9
g/l
1.2
1.3
3.25
4146
14588
(3018418) pH of Serum or Plasma
18967
83846
1.24
119.61
4.1
4.1
ph
7.4
7.4
0.34
3305
16443
(3009445) Proteinase 3 Ab [Units/volume] in Serum
3439
11544
1.58
118.54
1.7
1.4
u/ml
15.9
13.8
0.31
117
295
(3003327) Ova and parasites identified in Stool by Light microscopy
2918
9438
1.64
116.89
1.7
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
14947
64561
1.26
114.68
1.5
1.5
nmol/l
20.5
20.2
1.62
12892
55630
(3002582) Erythrocytes [#/volume] in Urine
19906
88799
1.23
114.22
3.4
3.2
e6/l
78.4
96.5
0.87
15252
67815
(3023368) Bacteria identified in Blood by Culture
17538
77214
1.24
113.53
4.3
4.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
18316
81059
1.24
112.94
3.3
3.1
e6/l
0.3
0.4
6.18
13707
60792
(3017446) Testosterone [Moles/volume] in Serum or Plasma
5763
21733
1.41
112.74
2.3
2.1
nmol/l
12.4
12.2
1.29
5066
19316
(3033658) Prothrombin time (PT) actual/Normal
16840
73900
1.24
111.97
4.1
4.0
%
91.1
89.9
7.67
16418
71999
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
2782
8998
1.64
111.36
1.6
1.6
titre
234.0
294.2
0.56
111
377
(40760892) CBC W Ordered Manual Differential panel - Blood
15289
66435
1.25
110.75
4.5
4.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
53908
265135
1.22
110.68
19.2
16.8
g/l
332.8
332.6
5.32
53512
262833
(3013512) EKG study
18003
79712
1.23
109.89
4.0
3.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
14178
61166
1.26
109.01
2.7
2.6
e6/l
5.3
5.8
4.02
12299
53365
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
4803
17753
1.44
104.51
3.4
3.3
pmol/l
4.5
4.5
0.12
4292
15829
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
11629
49283
1.27
102.92
2.9
2.7
e6/l
0.9
1.2
4.95
6608
27876
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7669
30829
1.33
100.35
1.8
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7773
31329
1.33
99.86
1.5
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
12142
51949
1.26
98.80
1.7
1.8
nmol/l
1135.8
1176.3
4.88
9145
39390
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
409
599
3.57
98.39
1.1
1.0
u/ml
8.1
13.1
0.89
62
48
(3002385) Erythrocyte distribution width [Ratio]
52302
257489
1.20
97.46
17.9
16.1
%
13.6
13.6
1.35
51360
251749
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
285
312
4.78
97.17
1.2
1.1
u/ml
7.9
7.3
0.07
216
208
(3017732) Neutrophils [#/volume] in Blood
5153
19592
1.40
95.48
2.6
2.9
e9/l
4.1
4.1
0.07
3993
15242
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
4226
15503
1.45
95.39
1.1
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7655
31023
1.32
94.25
1.8
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
28544
133558
1.19
94.02
9.6
9.5
e9/l
0.0
0.0
0.75
23155
109974
(3011397) Hemoglobin [Presence] in Urine by Test strip
15499
68614
1.23
91.54
3.8
3.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
2266
7318
1.63
91.01
1.3
1.3
u/ml
43.6
36.0
0.52
118
463
(3013139) Helicobacter pylori Ag [Presence] in Stool
4890
18575
1.40
90.90
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
3227
11350
1.50
89.75
2.0
1.9
u/l
39.1
39.5
0.54
2876
10090
(1002224) Polysomnography panel
3226
11349
1.50
89.62
1.1
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
3071
10691
1.52
89.61
1.2
1.2
u/ml
0.9
0.9
0.11
265
927
(44813793)
777
1754
2.32
88.47
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
2580
8673
1.57
87.92
2.8
2.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
2255
7358
1.62
86.90
1.6
1.4
iu/ml
14.1
13.0
0.16
59
161
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
1439
4160
1.82
85.37
1.1
1.1
au/ml
13.0
9.8
0.52
75
273
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
2956
10325
1.51
84.85
1.7
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
1343
3852
1.83
81.68
1.1
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
2483
8478
1.55
78.96
1.7
1.7
g/l
1.2
1.2
1.40
2351
8078
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
2076
6801
1.61
78.67
1.3
1.3
u/ml
7.9
9.2
0.30
280
1117
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
10730
46344
1.24
78.13
3.0
2.9
e6/l
2.7
3.0
2.51
5753
25101
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
6542
26594
1.31
77.80
2.5
2.5
u/l
47.5
45.0
0.11
5572
22800
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
2415
8235
1.55
77.23
1.7
1.7
g/l
0.2
0.2
0.35
2276
7821
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
11627
50764
1.23
76.38
2.9
3.0
mmol/l
2.4
2.4
6.36
9962
44349
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
885
2260
2.05
75.06
4.2
3.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
2034
6714
1.60
74.71
1.3
1.3
u/ml
3.4
7.4
2.20
185
727
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
16435
74374
1.20
74.54
1.7
1.6
mmol/l
1.4
1.4
1.46
14060
62596
(3011841) English Walnut IgE Ab [Units/volume] in Serum
180
162
5.80
74.25
1.1
1.1
u/ml
7.2
4.3
0.39
142
127
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
2442
8428
1.53
73.95
1.8
1.7
nmol/l
41.0
41.7
0.55
2368
8244
(3009508) Creatinine [Moles/volume] in Urine
19586
90075
1.18
73.72
3.3
3.2
mmol/l
7.8
7.9
0.36
16483
76076
(3047007) Chlamydophila sp Ab [Presence] in Serum
1312
3858
1.79
73.68
1.2
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5169
20472
1.34
73.48
1.7
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9505
40760
1.25
73.32
2.3
2.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
10616
46086
1.23
73.23
3.5
3.6
mmol/l
0.8
0.8
1.32
9857
42946
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
7855
32944
1.27
73.19
2.7
2.8
umol/l
7.9
8.7
2.55
6780
28444
(3000570) Elastase.pancreatic [Mass/mass] in Stool
2277
7755
1.55
73.18
1.4
1.4
ug/g
286.4
270.0
2.93
1297
4468
(3048929) Epstein Barr virus Ab [Presence] in Serum
2768
9881
1.48
71.37
1.3
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
1713
5485
1.64
71.03
1.2
1.2
u/ml
46.3
44.0
0.18
157
550
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
8144
34431
1.26
70.82
7.1
6.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
14015
62748
1.20
70.75
2.0
1.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
10530
45831
1.23
70.61
2.5
2.5
umol/l
13.5
13.0
8.83
9761
42356
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8645
36835
1.25
70.28
2.2
2.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
2358
8178
1.52
69.78
1.2
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
3065
11219
1.44
69.47
4.3
4.5
mmol/l
24.8
24.7
0.75
2855
10419
(42529406) Shigella sp [Presence] in Stool by Culture
2359
8202
1.52
69.00
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
2708
9696
1.47
68.75
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
3429
12837
1.41
68.71
4.1
4.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
479
971
2.58
68.20
1.9
2.4
ug/l
296.3
83.1
0.78
449
932
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
2404
8415
1.51
68.12
1.7
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
2330
8118
1.51
67.48
1.2
1.2
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
166
154
5.63
66.69
1.0
1.0
u/ml
0.2
0.2
0.12
106
90
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
179
180
5.19
66.67
1.1
1.1
u/ml
2.8
4.0
0.33
143
137
(3025941) Bacteria identified in Stool by Culture
4315
16888
1.35
66.06
1.3
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
299
470
3.33
65.29
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
19374
89843
1.17
63.74
4.9
4.7
ug/l
2.6
3.4
3.59
17460
80623
(3019150) Specific gravity of Urine by Refractometry
14333
64820
1.19
63.73
4.1
3.9
kg/l
1.0
1.0
0.58
2119
9925
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
5689
23281
1.30
63.73
2.4
2.3
ug/l
6.9
7.4
0.76
4905
20166
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
3168
11850
1.41
63.69
1.1
1.1
u/ml
3.1
8.8
1.01
33
198
(3018677) aPTT in Platelet poor plasma by Coagulation assay
10052
43971
1.22
63.49
2.1
2.2
s
29.8
29.9
1.01
9729
42690
(3026008) Bacteria identified in Urine by Culture
18950
87794
1.17
62.91
3.2
3.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
1731
5734
1.59
62.63
1.9
1.8
pmol/l
194.9
193.3
0.23
1624
5457
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
135
106
6.65
62.48
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
2074
7169
1.52
62.29
2.1
2.0
mg/l
10.9
11.0
0.23
1933
6678
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
5032
20346
1.31
61.51
1.2
1.2
iu/ml
134.8
143.1
0.67
1945
7504
(3019420) Tryptase [Mass/volume] in Serum or Plasma
554
1271
2.28
61.03
1.5
1.5
ug/l
8.3
8.0
0.10
492
1162
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
5081
20601
1.31
60.85
3.9
4.0
ng/l
87.3
92.5
3.14
4431
17754
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15540
71041
1.18
60.35
4.4
4.1
%
21.8
22.0
0.72
7183
33677
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
4553
18248
1.32
59.18
4.0
4.0
kpa
5.1
5.1
0.09
4227
16883
(3027231) Wheat IgE Ab [Units/volume] in Serum
281
455
3.23
58.78
1.1
1.1
u/ml
2.0
2.2
0.06
14
12
(3020961) Endomysium IgA Ab [Titer] in Serum
3664
14231
1.36
58.72
1.1
1.1
titre
218.0
222.6
0.03
72
411
(3009343) pH of Capillary blood
4500
18026
1.32
58.69
3.9
4.0
ph
7.4
7.4
1.03
504
2416
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
3057
11530
1.40
58.53
2.1
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
8578
37203
1.23
58.42
1.6
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
1653
5511
1.58
58.21
1.2
1.2
u/ml
6.5
11.3
0.43
12
89
(40768443) Skin Pathology biopsy report
3196
12162
1.39
58.07
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
17654
81755
1.17
57.90
3.3
3.3
mg/l
469.4
396.2
1.06
11185
52241
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
1663
5568
1.57
57.52
1.2
1.2
u/ml
3.8
6.2
0.76
109
435
(3026782) Osmolality of Urine
12785
57689
1.19
57.44
2.8
2.7
mosm/kgh2o
543.9
549.4
1.66
10766
49216
(3004789) Transferrin [Mass/volume] in Serum or Plasma
9608
42263
1.21
56.77
2.5
2.5
g/l
2.4
2.3
5.53
8897
38937
(3024891) Influenza virus A+B Ag [Presence] in Specimen
2140
7601
1.48
56.45
1.2
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
4351
17449
1.32
56.22
3.9
4.0
mmol/l
1.5
1.7
4.04
3251
12731
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
5488
22714
1.28
55.99
2.8
3.0
ng/l
174.4
218.4
11.80
4941
20659
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
1560
5182
1.58
55.79
1.3
1.2
titre
203.8
109.0
0.74
42
89
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
1725
5882
1.54
55.09
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
24249
115236
1.14
55.04
3.9
3.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
8944
39230
1.21
54.17
2.6
2.6
%
23.2
22.6
2.70
7597
33503
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
160
178
4.69
53.89
1.1
1.0
u/ml
2.5
1.3
0.23
91
83
(3004716) Salmonella sp identified in Stool by Organism specific culture
3930
15635
1.33
53.63
1.4
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
362
725
2.61
52.90
1.1
1.1
u/ml
6.5
22.9
0.55
227
383
(3003458) Phosphate [Moles/volume] in Serum or Plasma
8607
37696
1.22
52.80
5.8
6.1
mmol/l
1.0
1.1
2.47
8002
35102
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
8726
38303
1.21
52.28
1.8
1.8
%
1.4
1.4
0.15
7667
33951
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
2786
10557
1.39
51.83
1.9
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
8332
36510
1.21
50.68
25.0
24.0
inr
1.3
1.4
2.05
1300
5022
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
2228
8146
1.44
50.65
1.1
1.1
u/ml
4.6
6.0
0.63
273
1057
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
11296
50943
1.18
50.19
3.1
2.9
ug/l
0.7
0.8
14.34
7321
33065
(3004616) Nuclear Ab [Presence] in Serum
1012
3092
1.72
49.99
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
1235
4003
1.62
48.87
1.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
18393
86290
1.15
48.82
4.0
4.0
mg/mmol
9.1
9.8
0.83
11523
55347
(3002256) Pathology report gross observation
8535
37641
1.21
48.40
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
543
1371
2.07
47.65
1.3
1.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
228
371
3.21
47.46
1.3
1.3
u/ml
10.9
1.9
1.29
51
95
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
650
1762
1.93
47.03
2.4
2.8
e9/l
0.2
0.2
0.59
563
1504
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
152
183
4.34
47.01
1.1
1.0
u/ml
0.8
0.9
0.06
94
83
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
1060
3342
1.66
46.72
1.5
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
665
1827
1.91
46.29
2.4
2.7
e6/l
565.7
524.3
0.72
562
1504
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
3600
14442
1.32
46.19
2.5
2.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5465
23115
1.25
46.15
3.7
3.4
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
107
92
6.07
46.10
1.0
1.0
u/ml
0.7
1.8
0.35
88
65
(3004588) Protein electrophoresis panel - Serum or Plasma
4373
18026
1.28
45.74
2.3
2.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
567
1479
2.01
45.68
1.1
1.0
u/ml
0.9
0.7
0.14
103
189
(4015189)
286
547
2.73
45.61
2.5
2.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
5289
22322
1.25
45.49
2.5
2.5
g/l
66.5
66.5
0.21
4817
20272
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
1077
3435
1.64
45.44
1.5
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5501
23351
1.25
44.95
2.1
2.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
1691
6004
1.48
44.69
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7710
33914
1.21
44.66
1.8
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
1691
6008
1.48
44.55
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
1052
3359
1.64
44.20
1.5
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
3975
16265
1.29
44.00
1.7
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
1037
3312
1.64
43.54
1.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
1038
3319
1.64
43.39
1.5
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
626
1726
1.90
43.16
1.1
1.1
u/ml
4.0
1.2
1.47
229
478
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
1036
3316
1.64
43.13
1.5
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
616
1693
1.90
42.88
1.2
1.0
u/ml
8.3
3.7
0.63
213
392
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
5334
22699
1.24
42.52
2.6
2.7
ml/min/173m2
69.0
65.8
5.55
2131
8932
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5519
23618
1.24
41.77
1.4
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
601
1670
1.88
40.53
1.1
1.1
iu/ml
7.5
8.6
0.50
147
421
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
1784
6544
1.43
39.86
1.7
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
1322
4576
1.52
39.51
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
6146
26745
1.22
39.47
2.4
2.3
g/l
0.2
0.2
9.62
5705
24799
(3003396) Base excess in Arterial blood by calculation
7258
32093
1.20
39.43
7.5
7.3
mmol/l
1.1
1.0
0.69
5709
25110
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
13050
60517
1.15
39.34
1.6
1.7
pmol/l
36525354.0
31651333.1
0.40
10935
50106
(3003740) Influenza virus B Ag [Presence] in Specimen
1319
4579
1.51
38.89
1.1
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
7371
32696
1.19
38.63
4.0
4.2
u/l
239.4
244.6
1.84
6933
30934
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
7243
32082
1.20
38.56
7.5
7.4
kpa
5.1
5.1
0.04
6897
30592
(3000475) Leukocytes [#/volume] in Synovial fluid
1757
6467
1.43
38.54
1.6
1.6
e6/l
12460.9
14374.1
0.85
1287
4694
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
1345
4700
1.50
38.45
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
1723
6323
1.43
38.41
1.7
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
7235
32066
1.20
38.24
7.5
7.3
kpa
12.2
12.6
6.49
6887
30563
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
971
3157
1.61
38.06
1.1
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2426
9453
1.35
37.89
2.2
2.3
g/l
3.0
3.1
1.55
1868
7326
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11322
52100
1.16
37.78
1.7
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
2407
9375
1.35
37.70
1.4
1.4
u/l
9.7
9.6
0.20
1964
7597
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
133
173
4.01
37.66
1.1
1.0
u/ml
0.6
0.4
0.23
84
77
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2556
10059
1.34
37.38
2.2
2.2
g/l
3.8
3.8
0.42
1825
7141
(3045414) Leukocytes [Presence] in Urine
3137
12718
1.30
37.15
1.9
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2561
10091
1.33
37.14
2.2
2.2
g/l
7.3
7.4
1.09
1923
7460
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2558
10080
1.33
37.08
2.2
2.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
784
2430
1.69
36.93
5.3
4.5
u/ml
103.4
126.5
0.43
246
731
(3014111) Lactate [Moles/volume] in Serum or Plasma
5779
25159
1.21
36.83
7.2
7.2
mmol/l
1.3
1.4
3.56
5552
24190
(3025018) Bordetella pertussis Ab [Titer] in Serum
548
1527
1.88
36.71
1.2
1.2
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
124
157
4.12
36.29
1.7
1.6
mg/l
1.3
2.1
0.85
83
99
(3027945) Reticulocytes/100 erythrocytes in Blood
7181
31969
1.19
35.97
2.7
2.6
%
1.7
1.8
0.88
6313
28299
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
2303
8980
1.35
35.81
1.6
1.6
iu/ml
2.8
6.7
0.72
493
1921
(3011412) CD3 cells [#/volume] in Blood
827
2624
1.65
35.71
2.4
2.5
e9/l
1.4
1.1
7.89
475
1612
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
982
3257
1.58
35.50
2.0
2.0
mg/l
23.4
28.0
1.71
255
861
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
4380
18615
1.24
35.12
1.9
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
608
1783
1.78
34.73
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
1210
4230
1.50
34.57
1.6
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
6477
28672
1.19
34.49
7.9
7.7
%
95.7
95.7
0.07
6232
27598
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
120
155
4.04
34.32
1.6
1.6
mg/l
1.4
2.2
1.12
92
103
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
120
155
4.04
34.32
1.6
1.6
mg/l
3.3
2.6
0.41
88
100
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
120
155
4.04
34.32
1.6
1.6
mg/l
2.0
2.8
0.57
86
106
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
120
155
4.04
34.32
1.6
1.6
mg/l
1.8
2.4
0.41
77
104
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
120
155
4.04
34.32
1.6
1.6
mg/l
1.4
0.7
1.09
84
98
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
120
155
4.04
34.32
1.6
1.6
mg/l
2.2
2.4
0.11
93
108
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
120
155
4.04
34.32
1.6
1.6
mg/l
1.6
1.7
0.12
76
86
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
120
155
4.04
34.32
1.6
1.6
mg/l
4.0
3.7
0.13
84
86
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
120
155
4.04
34.32
1.6
1.6
mg/l
0.8
1.5
0.92
77
96
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
2212
8634
1.35
34.17
1.9
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
535
1526
1.83
33.42
6.9
6.4
—
—
—
0
0
(4094501)
1875
7157
1.38
33.36
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
1057
3631
1.53
32.80
1.6
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
107
132
4.23
32.34
1.2
1.3
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
422
1124
1.96
32.30
2.1
2.0
umol/l
2.0
1.9
0.84
389
1071
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2371
9428
1.32
32.29
2.2
2.2
g/l
10.1
10.3
1.94
1978
7855
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
2175
8555
1.34
31.93
2.3
2.4
g/l
0.9
0.9
0.22
1870
7310
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10597
49058
1.15
31.91
1.5
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
123
172
3.73
31.88
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
2197
8657
1.33
31.86
3.3
3.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
1225
4375
1.47
31.55
1.4
1.3
u/l
25.5
25.1
0.17
993
3657
(3018851) Theophylline [Moles/volume] in Serum or Plasma
119
164
3.79
31.43
1.7
1.6
umol/l
47.4
45.8
0.17
119
164
(3017181) Myelocytes/100 leukocytes in Blood
5606
24691
1.20
31.43
4.1
4.1
%
0.8
1.0
2.64
1520
6870
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
2670
10834
1.30
31.38
1.7
1.6
mg/l
3.6
3.5
0.19
1888
7429
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
855
2829
1.58
31.29
1.8
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
3982
16981
1.24
30.86
1.5
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
1009
3482
1.52
30.69
3.1
2.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
707
2242
1.65
30.68
1.8
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
707
2242
1.65
30.68
1.8
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
707
2242
1.65
30.68
1.8
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
787
2572
1.60
30.33
1.9
1.7
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
327
812
2.10
30.18
1.3
1.2
%
109.7
111.7
0.63
290
724
(3038026) Centromere Ab [Units/volume] in Serum
647
2016
1.68
30.01
1.2
1.2
u/ml
59.7
48.6
0.29
28
95
(3041096) Erythrocytes [Presence] in Urine by Automated
17093
81788
1.12
29.99
3.3
3.2
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
105
136
4.03
29.99
1.0
1.0
u/ml
2.1
1.3
0.33
76
85
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
346
883
2.05
29.78
1.3
1.2
g/l
0.3
0.3
0.77
285
692
(44790047)
902
3064
1.54
29.50
1.6
1.6
—
—
—
0
0
(44790049)
902
3064
1.54
29.50
1.6
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
5109
22439
1.20
29.46
4.0
3.9
%
0.6
0.7
0.77
1106
4949
(44790048)
902
3065
1.54
29.46
1.6
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
409
1116
1.92
29.29
4.4
3.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
598
1836
1.70
29.28
1.3
1.2
—
—
—
0
0
(44806118)
901
3065
1.54
29.28
1.6
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
629
1966
1.67
28.87
1.2
1.2
u/ml
87.5
69.3
0.62
25
100
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
630
1972
1.67
28.76
1.2
1.2
u/ml
45.2
44.4
0.03
42
157
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
382
1025
1.95
28.72
2.1
2.3
%
28.9
28.7
0.10
361
974
(3002173) Hemoglobin [Mass/volume] in Arterial blood
5934
26472
1.18
28.70
8.4
8.1
g/l
122.9
121.2
8.41
5739
25517
(3021440) Promyelocytes/100 leukocytes in Blood
5323
23524
1.19
28.66
4.2
4.2
%
0.1
0.1
0.15
1405
6376
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
1981
7815
1.33
28.52
2.1
2.2
g/l
37.9
37.6
1.51
1703
6673
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
1861
7276
1.34
28.47
1.4
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1527
5786
1.38
28.46
1.5
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
591
1826
1.69
28.31
1.3
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
604
1882
1.68
28.06
1.2
1.2
u/ml
5.3
10.1
0.69
40
122
(3014576) Chloride [Moles/volume] in Serum or Plasma
7831
35778
1.16
28.03
7.5
7.2
mmol/l
104.5
104.5
0.14
7672
34988
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
1043
3696
1.48
27.99
1.5
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
1125
4050
1.46
27.88
1.4
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
5542
24642
1.19
27.81
8.7
8.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
481
1408
1.79
27.77
2.5
2.5
u/ml
922.4
1196.6
1.08
474
1389
(3029937) Albumin [Presence] in Urine by Test strip
16806
80619
1.11
27.74
4.3
3.9
estimate
0.0
0.0
0.11
5590
27694
(3019060) Gas panel - Arterial blood
4210
18262
1.21
27.60
4.8
4.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
421
1189
1.85
27.25
1.8
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
1917
7579
1.33
27.21
2.2
2.2
g/l
0.0
0.0
0.27
1754
6903
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
1369
5152
1.39
26.60
1.6
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
1274
4739
1.41
26.47
1.8
1.7
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
981
3474
1.48
26.45
1.2
1.3
u/ml
57.3
51.9
0.21
49
239
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
650
2101
1.62
26.27
1.1
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
1799
7086
1.33
26.21
1.9
1.9
iu/l
9.3
19.4
0.52
650
2602
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
617
1974
1.63
25.98
2.5
2.7
e6/l
753.2
710.4
0.26
266
745
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
648
2100
1.61
25.93
1.1
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
685
2251
1.59
25.90
1.2
1.2
titre
170.3
189.1
0.24
116
381
(3006245) CD3-CD19+ cells/100 cells in Blood
382
1064
1.88
25.83
2.2
2.5
%
12.0
11.0
0.66
355
995
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
647
2099
1.61
25.78
1.1
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
683
2246
1.59
25.76
1.2
1.2
titre
216.6
170.0
0.25
29
71
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
643
2085
1.61
25.68
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
643
2088
1.61
25.53
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
2804
11747
1.25
25.46
1.6
1.6
mu/l
291.1
321.7
3.50
2542
10549
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
2393
9839
1.28
25.40
2.2
2.4
ug/l
408.9
575.6
1.29
2232
9190
(40759836) Histone Ab [Presence] in Serum by Immunoblot
641
2084
1.61
25.34
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
4327
19007
1.20
24.81
3.0
2.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
1317
4990
1.38
24.61
1.5
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
4994
22251
1.18
24.37
4.2
4.2
%
0.0
0.3
5.19
1182
5411
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
1048
3821
1.44
24.36
1.2
1.3
nmol/l
0.2
0.3
0.26
74
236
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
1765
7013
1.32
24.23
2.2
2.3
g/l
0.0
0.0
0.14
1608
6361
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
974
3506
1.45
24.23
1.4
1.4
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
83
106
4.09
24.20
1.0
1.0
u/ml
26.6
12.0
1.29
70
84
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
1741
6907
1.32
24.16
2.2
2.3
g/l
0.0
0.0
0.00
1603
6341
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
498
1535
1.70
24.16
1.6
1.4
u/l
5.5
6.0
0.80
406
1298
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
3516
15207
1.22
23.70
9.6
9.9
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
1047
3838
1.43
23.66
1.2
1.3
nmol/l
0.6
1.4
1.17
1001
3692
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
3429
14799
1.22
23.62
9.7
9.6
mmol/l
24.4
24.3
0.94
3207
13780
(3023520) Reticulocytes [#/volume] in Blood
5252
23603
1.17
23.07
2.6
2.7
e9/l
69.1
69.4
0.26
3949
17720
(3008536) Aspergillus sp Ab [Presence] in Serum
205
470
2.28
23.03
1.9
2.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
957
3469
1.44
22.98
1.2
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
573
1858
1.61
22.95
1.7
1.7
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
106
170
3.25
22.85
1.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
646
2159
1.56
22.83
1.1
1.1
u/ml
61.3
56.8
—
7
27
(3023323) Follitropin [Units/volume] in Serum or Plasma
3359
14520
1.22
22.77
1.4
1.4
iu/l
25.6
26.8
1.37
2903
12363
(3020779) Urea [Moles/volume] in Serum or Plasma
5676
25691
1.16
22.76
7.2
7.7
mmol/l
9.3
9.8
5.07
5396
24419
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
661
2224
1.55
22.69
1.4
1.3
pmol/l
61.5
91.5
1.35
225
670
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
425
1281
1.73
22.37
1.6
2.1
%
138.3
145.2
0.93
397
1205
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
1119
4195
1.40
22.32
1.6
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
1678
6699
1.31
22.30
1.4
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
1260
4826
1.37
22.09
1.2
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
4015
17720
1.19
21.82
9.8
9.3
%
93.9
93.9
0.33
4000
17656
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
299
816
1.91
21.58
1.0
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
1771
7164
1.30
21.38
1.3
1.4
mg/l
511.7
535.9
0.62
1668
6836
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
1668
6696
1.31
21.32
1.3
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
325
917
1.85
21.25
1.1
1.2
%
110.1
105.9
1.01
291
829
(1175426) CD3 cells/100 lymphocytes in Blood
633
2144
1.54
21.15
2.1
2.2
%
73.0
72.1
0.70
606
2062
(3007566) Smooth muscle Ab [Titer] in Serum
1948
7993
1.28
21.07
1.3
1.3
titre
117.0
123.2
0.12
182
724
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
3994
17674
1.19
21.05
9.8
9.3
%
0.7
0.7
0.49
3968
17568
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
3145
13612
1.21
21.05
2.4
2.3
u/l
4295.9
6469.4
4.33
1205
5479
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
593
1982
1.56
21.00
2.1
2.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
437
1353
1.69
20.95
2.0
1.8
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
1009
3761
1.40
20.84
1.1
1.1
g/l
1.5
1.5
3.54
906
3417
(3034770) Mitochondria Ab [Titer] in Serum
1915
7853
1.28
20.81
1.2
1.2
titre
1036.4
896.0
0.34
50
220
(3044941) Cell count panel - Synovial fluid
1108
4198
1.38
20.80
1.4
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
313
881
1.86
20.63
1.2
1.1
%
91.9
89.7
0.37
148
422
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
319
904
1.84
20.60
1.1
1.1
%
90.7
90.1
0.12
149
428
(3045424) Erythrocytes [Presence] in Urine
1240
4792
1.36
20.59
1.5
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
621
2111
1.54
20.44
2.1
2.2
%
12.9
13.9
1.21
350
958
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
435
1355
1.68
20.41
2.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
435
1355
1.68
20.41
2.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
435
1355
1.68
20.41
2.0
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
1569
6285
1.31
20.39
1.3
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
1119
4264
1.37
20.30
1.1
1.1
u/ml
2.5
3.1
1.24
539
2025
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
3988
17701
1.18
20.30
9.7
9.2
%
1.4
1.4
0.47
3962
17581
(3020717) Zinc [Moles/volume] in Serum or Plasma
429
1337
1.68
20.10
1.6
1.5
umol/l
25.3
24.1
0.32
407
1273
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
280
775
1.89
19.46
3.0
3.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
832
3040
1.43
19.25
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
2375
10089
1.23
19.08
1.3
1.3
miu/ml
224.0
223.9
0.00
1127
4600
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
3295
14463
1.20
19.02
4.6
4.7
mmol/l
24.2
24.0
2.55
2980
13046
(3047181) Lactate [Moles/volume] in Blood
2107
8843
1.25
18.89
5.3
5.9
mmol/l
1.3
1.3
0.62
1867
7814
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
1476
5927
1.30
18.88
1.3
1.3
u/ml
259.7
257.1
0.12
920
3815
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
805
2938
1.43
18.75
1.1
1.1
au/ml
38.2
79.9
1.18
11
33
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
350
1055
1.73
18.53
2.2
2.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
617
2144
1.50
18.42
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
283
802
1.84
18.34
2.1
2.5
e6/l
503.2
837.6
0.40
166
430
(3027008) Opiates [Presence] in Urine
3220
14151
1.19
18.34
2.1
2.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1484
5989
1.30
18.30
5.9
5.8
iu/ml
1197.4
1836.0
0.28
216
878
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
345
1040
1.73
18.27
2.2
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
3227
14190
1.19
18.26
2.2
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
345
1041
1.73
18.21
2.2
2.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
145
317
2.39
18.20
1.1
1.1
u/ml
0.5
0.2
0.50
94
192
(3016879) Cocaine [Presence] in Urine
2994
13084
1.20
18.13
2.2
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
2219
9411
1.24
18.11
3.1
3.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
1472
5946
1.30
18.04
1.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
3169
13930
1.19
18.01
2.1
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
942
3564
1.38
17.91
1.5
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
1554
6329
1.29
17.89
1.3
1.3
mmol/l
3.7
3.8
0.97
1448
5950
(3000764) Benzodiazepines [Presence] in Urine
3196
14069
1.19
17.87
2.2
2.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
3915
17547
1.17
17.71
7.4
7.1
mmol/l
24.6
24.5
0.50
3665
16364
(3037121) Protein [Mass/volume] in Urine
2318
9903
1.23
17.67
3.2
3.3
g/l
0.3
0.3
0.20
989
4590
(3021447) Carbon dioxide [Partial pressure] in Venous blood
5914
27323
1.14
17.67
4.2
4.2
kpa
5.9
5.8
3.06
5719
26507
(3028433) Virus identified in Specimen by Culture
300
878
1.78
17.58
1.2
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
814
3016
1.41
17.49
1.1
1.1
au/ml
6.4
32.8
—
6
17
(3002032) Base excess in Venous blood by calculation
5897
27259
1.14
17.47
4.2
4.2
mmol/l
1.9
1.8
2.51
4831
22207
(3028707) Methadone [Presence] in Urine by Screen method
1462
5928
1.29
17.43
2.9
2.9
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
91
159
2.99
17.30
1.6
1.2
u/ml
13.1
4.2
0.69
83
124
(3023420) DNA double strand Ab [Units/volume] in Serum
820
3052
1.41
17.19
1.5
1.5
iu/ml
29.6
33.9
0.42
41
139
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
676
2434
1.45
16.98
2.3
2.3
nmol/l
19.3
19.4
0.10
642
2313
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
648
2315
1.46
16.94
1.1
1.1
mg/l
40.5
44.2
0.86
557
1904
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
1917
8063
1.25
16.90
1.3
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
808
3011
1.40
16.83
1.3
1.3
nmol/l
31.9
27.3
0.25
11
18
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
728
2664
1.43
16.79
1.1
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
626
2229
1.47
16.65
1.1
1.1
mg/l
259.6
272.8
0.64
560
1936
(3012544) pH of Venous blood
6086
28277
1.13
16.63
4.2
4.2
ph
7.4
7.4
1.09
34
140
(3001019) Free T4 and TSH panel - Serum or Plasma
3560
15917
1.17
16.60
1.7
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
2509
10875
1.21
16.59
2.3
2.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
504
1718
1.53
16.51
1.0
1.0
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
83
142
3.05
16.35
1.1
1.0
u/ml
8.0
6.7
0.24
65
74
(3010144) Erythrocytes [#/volume] in Synovial fluid
700
2556
1.43
16.35
1.4
1.4
e6/l
158568.8
99216.2
1.04
459
1790
(3037692) Legionella sp identified in Specimen by Organism specific culture
296
883
1.75
16.32
1.5
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
2402
10384
1.21
16.32
2.6
2.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
317
965
1.72
16.30
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
1000
3888
1.35
16.09
1.3
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
2231
9612
1.22
15.70
1.5
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
305
934
1.71
15.39
1.5
1.8
u/ml
66549.6
10708.2
0.77
41
117
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
241
689
1.83
15.31
1.2
1.3
nmol/l
122.3
132.7
0.41
182
501
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
2328
10109
1.21
15.13
1.3
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
589
2122
1.45
14.83
1.1
1.1
mg/l
287.0
430.1
0.52
517
1921
(3019832) Treponema pallidum Ab [Presence] in Serum
7483
35430
1.11
14.73
1.7
1.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
1093
4365
1.31
14.67
2.1
2.1
titre
6.4
6.8
0.04
21
126
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
449
1536
1.53
14.55
1.1
1.1
u/l
1.0
1.1
1.02
222
683
(3035320) C reactive protein [Mass/volume] in Body fluid
573
2062
1.45
14.52
2.7
2.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
724
2720
1.39
14.47
1.6
1.5
mosm/kgh2o
278.4
280.1
1.26
545
2126
(3018001) Oat IgE Ab [Units/volume] in Serum
84
157
2.79
14.35
1.0
1.0
u/ml
0.2
0.2
0.05
33
52
(3016244) Insulin [Units/volume] in Serum or Plasma
536
1909
1.47
14.33
3.2
3.1
mu/l
30.9
25.1
1.91
505
1780
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
798
3058
1.36
14.16
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
890
3471
1.34
14.10
1.6
1.6
%
56.5
58.1
0.53
575
2215
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
924
3630
1.33
13.95
1.8
1.8
titre
1052.9
4348.9
3.04
31
155
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
846
3281
1.35
13.92
1.1
1.1
iu/ml
1.6
2.1
0.45
24
72
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
355
1163
1.59
13.90
2.2
1.9
umol/l
29.1
28.3
0.69
345
1118
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
452
1565
1.51
13.89
2.6
2.7
%
41.1
38.8
1.16
177
497
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1963
8456
1.22
13.88
3.1
3.3
mg/l
35.9
45.7
3.00
1617
6806
(3008757) Leukocyte morphology finding [Identifier] in Blood
796
3061
1.36
13.83
3.8
3.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
1218
4981
1.28
13.70
1.6
1.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
204
574
1.86
13.68
1.6
1.5
ug/l
0.4
0.4
0.18
140
369
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1910
8221
1.22
13.63
3.1
3.3
ratio
2.2
4.6
1.30
148
658
(21494815) CD4 cells/100 lymphocytes in Specimen
665
2489
1.40
13.63
2.2
2.3
%
42.4
40.4
0.61
106
295
(3034860) Kappa light chains.free [Mass/volume] in Serum
1962
8474
1.21
13.52
3.1
3.3
mg/l
52.2
71.0
1.14
1612
6823
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
756
2896
1.36
13.48
1.1
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
1518
6389
1.24
13.40
1.4
1.5
e6/l
2790.7
1935.3
0.23
1241
5151
(44816559) Phosphatidylethanol [Mass/volume] in Blood
1366
5682
1.26
13.37
1.4
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
1157
4718
1.28
13.33
1.5
1.4
mmol/l
63.3
63.2
0.02
928
3709
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
1515
6383
1.24
13.26
1.3
1.5
e6/l
26.6
33.5
0.45
1182
4888
(3014051) Protein [Presence] in Urine by Test strip
1523
6421
1.24
13.25
2.2
2.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1127
4584
1.29
13.24
3.2
3.1
u/ml
9017.6
2806.4
0.36
68
263
(3017354) Segmented neutrophils/100 leukocytes in Blood
716
2731
1.37
13.13
3.4
3.2
%
56.9
58.7
1.10
462
1731
(3036312) Salmon IgE Ab [Units/volume] in Serum
72
130
2.89
13.09
1.1
1.1
u/ml
1.6
1.6
0.02
55
88
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
444
1553
1.49
13.04
1.1
1.1
nmol/l
4.3
6.0
0.43
91
294
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
46
61
3.93
13.00
1.0
1.0
u/ml
0.2
0.2
0.09
25
27
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
41
50
4.28
12.79
1.0
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
2004
8733
1.20
12.61
2.6
2.7
%
179.1
188.7
5.02
1870
8294
(3036489) Thrombin time
2551
11357
1.18
12.59
2.2
2.3
s
21.4
21.6
0.80
2176
9929
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
301
972
1.62
12.55
1.6
2.1
%
157.6
169.9
1.07
281
913
(3015183) Erythrocyte sedimentation rate
415
1444
1.50
12.52
1.2
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
3385
15410
1.15
12.51
2.8
2.7
e6/l
0.3
0.3
0.70
3289
15000
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
512
1860
1.44
12.44
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
956
3850
1.30
12.17
1.6
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
1129
4647
1.27
12.12
1.2
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
476
1716
1.45
12.06
1.3
1.3
umol/l
5.0
5.1
0.35
433
1586
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
1047
4279
1.28
11.91
1.3
1.3
u/l
39.5
34.6
0.39
920
3714
(3016031) Almond IgE Ab [Units/volume] in Serum
81
165
2.56
11.90
1.0
1.1
u/ml
1.5
0.5
1.49
48
99
(3010503) CD19 cells [#/volume] in Blood
457
1640
1.46
11.87
2.6
2.6
e9/l
0.4
0.3
0.36
446
1594
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
477
1727
1.44
11.83
2.8
2.9
ug/l
18.8
27.1
—
5
27
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
180
512
1.83
11.76
1.1
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
180
512
1.83
11.76
1.1
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
180
513
1.83
11.69
1.1
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
646
2472
1.37
11.68
1.3
1.3
titre
—
—
—
0
0
(3039000) Anion gap in Blood
1452
6178
1.23
11.66
6.2
6.9
mmol/l
11.2
11.3
0.43
1307
5577
(3018572) Chloride [Moles/volume] in Blood
1452
6179
1.23
11.65
6.2
6.9
mmol/l
105.1
105.1
0.06
1307
5579
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
1480
6313
1.23
11.61
1.4
1.5
u/ml
23.2
19.9
0.31
32
107
(3037756) Immunofixation for Serum or Plasma
1318
5558
1.24
11.51
1.6
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
321
1077
1.56
11.47
1.1
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
297
979
1.58
11.45
2.3
2.1
ug/l
64.0
64.9
0.06
291
956
(3034274) Bile acid [Moles/volume] in Serum --fasting
1089
4496
1.27
11.43
2.2
2.3
umol/l
7.6
7.2
0.17
808
3282
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
38
48
4.13
11.42
1.0
1.0
u/ml
0.2
0.3
0.34
20
20
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
485
1775
1.43
11.38
2.3
2.4
%
98.7
96.7
0.61
444
1665
(3024928) Oxygen saturation in Venous blood
1411
6003
1.23
11.36
3.6
3.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
700
2727
1.34
11.30
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
165
465
1.85
11.12
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
2877
13061
1.15
11.08
1.8
1.7
g/l
1.5
1.5
0.53
2450
11146
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
1488
6384
1.22
11.06
1.4
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
1937
8523
1.19
11.02
1.8
1.7
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
51
83
3.21
10.99
1.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
200
601
1.74
10.96
1.2
1.2
pmol/l
311.5
334.5
0.22
134
453
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
204
617
1.73
10.93
1.2
1.3
%
109.3
105.6
0.75
196
577
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
3989
18537
1.13
10.84
7.5
7.7
mmol/l
24.9
24.7
3.24
3958
18362
(3011985) Renin [Units/volume] in Plasma
938
3835
1.28
10.70
1.5
1.6
mu/l
68.2
63.7
0.26
827
3452
(4027681)
487
1807
1.41
10.63
1.2
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
1150
4823
1.25
10.60
1.5
1.4
nmol/l
0.4
0.4
0.05
893
3801
(4024509)
659
2573
1.34
10.52
1.6
1.6
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
195
592
1.72
10.35
1.1
1.2
%
83.5
87.3
0.33
48
177
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
563
2152
1.37
10.32
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
1481
6398
1.21
10.30
1.6
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
1561
6781
1.20
10.25
2.2
2.2
g/l
131.9
130.0
2.19
1091
5091
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
442
1623
1.42
10.25
1.3
1.3
titre
291.2
478.5
0.51
33
124
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
2457
11096
1.16
10.19
2.0
2.0
ug/l
1.9
2.4
1.02
2162
9750
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
180
537
1.75
10.15
1.4
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
146
408
1.87
10.15
1.2
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
430
1574
1.43
10.15
1.3
1.3
titre
57.4
66.6
0.34
35
129
(3007700) Barley IgE Ab [Units/volume] in Serum
56
102
2.86
10.13
1.0
1.0
u/ml
0.3
0.7
0.48
30
45
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
283
953
1.55
10.03
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
735
2939
1.31
9.97
1.5
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5956
28427
1.10
9.92
1.7
1.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
135
371
1.90
9.87
1.5
1.6
—
—
—
0
0
(3020891) Body temperature
2473
11204
1.16
9.84
5.3
4.9
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
473
1772
1.39
9.81
1.4
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
256
847
1.58
9.80
1.1
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
107
271
2.06
9.79
1.1
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
251
827
1.58
9.78
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
4784
22599
1.11
9.77
3.7
3.6
kpa
4.7
4.6
0.59
4600
21839
(3044927) Protein electrophoresis panel - Urine
650
2564
1.32
9.72
1.2
1.2
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
40
60
3.48
9.72
1.1
1.0
u/ml
0.4
0.5
0.03
19
24
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
311
1078
1.51
9.69
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
465
1741
1.39
9.69
1.4
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
617
2420
1.33
9.61
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
558
2157
1.35
9.57
1.8
1.8
mmol/l
6.8
6.7
0.28
409
1603
(3007542) Rye IgE Ab [Units/volume] in Serum
62
124
2.61
9.53
1.1
1.0
u/ml
0.4
0.5
0.23
27
54
(4035726)
5250
24954
1.10
9.51
1.4
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
1463
6366
1.20
9.48
3.2
3.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
191
592
1.68
9.46
1.2
1.2
%
73.1
75.9
0.24
44
169
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
1360
5880
1.21
9.43
1.4
1.5
u/ml
115.2
109.2
0.78
273
1327
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
864
3557
1.27
9.39
1.3
1.4
pmol/l
313.0
303.0
0.23
665
2766
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
2054
9214
1.17
9.33
2.7
2.9
g/l
3.6
3.6
0.32
1948
8793
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
1072
4530
1.24
9.29
1.2
1.3
u/ml
4.1
3.9
0.18
480
2061
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
261
880
1.55
9.25
1.1
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
361
1305
1.44
9.17
1.7
1.6
mmol/24h
5.9
5.7
0.09
30
97
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
351
1264
1.45
9.10
1.7
1.6
nmol/l
3.9
9.5
0.66
278
1073
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
309
1085
1.49
9.09
1.9
1.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
180
558
1.68
8.94
1.2
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
1888
8447
1.17
8.89
4.9
4.4
mmol/l
3.9
3.9
0.45
1773
7927
(3018405) Lactate [Moles/volume] in Arterial blood
2176
9843
1.16
8.89
4.7
4.1
mmol/l
1.3
1.4
1.83
2132
9676
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
39
62
3.28
8.77
1.0
1.1
g/l
0.2
0.2
0.05
31
47
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
491
1894
1.35
8.60
1.5
1.6
u/ml
23.7
25.0
0.21
83
398
(3017315) Amylase [Enzymatic activity/volume] in Urine
407
1523
1.40
8.58
1.2
1.3
u/l
350.0
302.4
0.30
372
1428
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
355
1299
1.43
8.49
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
1403
8656
0.84
8.46
1.8
1.8
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
18
5.79
8.46
1.0
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
1086
4644
1.22
8.46
3.2
3.3
%
1.3
1.5
0.71
833
3600
(4306422)
1057
4508
1.23
8.45
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
203
661
1.60
8.39
1.1
1.1
—
—
—
0
0
(4211845)
401
1503
1.39
8.38
3.4
2.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
2540
11668
1.14
8.35
1.9
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
417
1576
1.38
8.31
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
368
1365
1.41
8.18
3.5
2.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
21741
109296
1.05
8.18
2.7
2.7
—
—
—
0
0
(4268621)
745
3069
1.27
8.13
2.3
2.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
315
1139
1.44
8.06
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
201
661
1.59
8.00
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
763
3159
1.26
8.00
1.3
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
729
3004
1.27
7.95
3.5
3.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
4047
19161
1.11
7.95
1.4
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
149
454
1.71
7.94
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
351
1299
1.41
7.93
1.1
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
106
291
1.90
7.88
1.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
351
1302
1.41
7.83
1.5
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
556
2218
1.31
7.80
1.2
1.3
mmol/l
1.9
2.1
4.11
509
2057
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
351
1303
1.41
7.80
1.5
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
404
1538
1.37
7.74
1.1
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
170
541
1.64
7.73
1.2
1.4
mu/l
123.0
72.3
0.58
127
408
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
283
1011
1.46
7.73
2.4
2.7
ug/l
1.3
1.2
0.11
266
953
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
769
3201
1.26
7.72
1.6
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
1563
6973
1.17
7.70
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
1054
4540
1.21
7.69
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
492
1937
1.33
7.59
1.2
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
170
544
1.63
7.58
1.8
1.8
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
894
3794
1.23
7.55
6.2
6.3
mg/l
11.7
11.5
0.61
824
3460
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
72
174
2.16
7.51
2.0
1.9
ug/g
169.5
177.4
0.13
60
151
(3051651) Icteric interference index of Serum or Plasma
446
1738
1.34
7.39
3.8
4.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
126
374
1.76
7.38
2.0
1.9
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
1013
4368
1.21
7.34
1.1
1.1
%
119.0
117.1
1.08
912
3942
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
302
1105
1.43
7.31
1.1
1.1
ng/l
619.2
570.8
0.05
69
254
(3024263) Appearance of Synovial fluid
374
1421
1.37
7.29
1.6
1.8
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
117
343
1.78
7.15
1.7
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
2854
13341
1.12
7.13
3.1
3.1
%
1.3
1.3
1.57
2840
13272
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
730
3051
1.25
7.12
1.3
1.2
u/l
60.6
68.3
1.13
480
2093
(3036071) Salmonella sp Ab [Titer] in Serum
257
918
1.46
7.07
1.1
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
445
1746
1.33
7.07
2.2
1.9
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
2796
13062
1.12
7.06
3.1
3.1
%
0.6
0.7
2.25
2689
12556
(3001186) Copper [Moles/volume] in Serum or Plasma
200
678
1.54
7.06
1.4
1.3
umol/l
16.2
16.9
1.43
175
605
(3001964) Herpes simplex virus Ag [Presence] in Specimen
242
855
1.48
7.04
1.5
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
241
851
1.48
7.03
1.2
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
394
1519
1.35
7.03
1.4
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
2107
9688
1.14
6.90
2.4
2.7
%
92.9
91.6
1.85
1946
9031
(3007456) Orange IgE Ab [Units/volume] in Serum
28
42
3.48
6.89
1.0
1.0
u/ml
0.1
0.1
0.05
20
23
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
1026
4461
1.20
6.85
1.3
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
1084
4739
1.20
6.82
1.2
1.2
u/ml
4.1
3.7
0.23
389
1679
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
571
2331
1.28
6.80
1.4
1.2
u/ml
—
40.1
—
0
7
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
205
705
1.52
6.80
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
350
1332
1.37
6.79
2.5
2.0
umol/l
128.8
138.5
0.23
195
662
(1761482) Bacteria [#/volume] in Urine by Culture
1260
7692
0.85
6.78
4.7
4.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
632
2623
1.26
6.59
2.8
2.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
514
2080
1.29
6.57
1.1
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
164
541
1.58
6.54
1.1
1.1
umol/24h
0.6
0.8
0.68
78
256
(3006442) Creatine [Moles/volume] in Serum or Plasma
505
2043
1.29
6.48
1.6
1.5
umol/l
66.3
70.5
0.70
31
164
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
307
2182
0.73
6.45
12.4
13.4
nmol/l
763.6
1534.4
0.87
294
2108
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
1120
4943
1.18
6.37
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
203
708
1.50
6.34
1.1
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
326
2289
0.74
6.32
17.1
18.7
nmol/l
1341.8
2517.8
0.86
309
2196
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
481
1941
1.29
6.31
1.5
1.4
u/l
12.4
12.9
0.96
468
1873
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
33
59
2.92
6.29
1.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
991
4336
1.19
6.23
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
140
450
1.62
6.23
1.5
1.4
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
107
320
1.74
6.19
1.3
1.3
titre
62.8
171.0
—
5
29
(3001686) Cold agglutinin [Titer] in Serum or Plasma
143
463
1.61
6.18
1.2
1.4
titre
50.6
185.9
1.25
14
52
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
189
654
1.51
6.14
1.1
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
221
791
1.46
6.10
1.3
1.2
g/l
41.0
39.9
0.55
122
431
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
110
335
1.71
5.99
1.3
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
364
1426
1.33
5.93
1.5
1.6
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
130
416
1.63
5.91
1.8
1.7
pmol/l
43.3
54.2
0.37
103
354
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
22
31
3.70
5.91
1.0
1.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
446
1800
1.29
5.88
1.3
1.4
mmol/l
33.8
34.6
0.30
374
1554
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
1177
5254
1.17
5.88
3.0
3.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
380
1502
1.32
5.83
1.5
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
362
1421
1.33
5.83
1.1
1.1
iu/ml
5.1
3.9
0.44
29
107
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
733
3146
1.22
5.69
2.9
3.4
nmol/l
4.9
8.2
1.00
701
3061
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
510
2107
1.26
5.61
1.9
1.9
mg/l
3.7
3.8
0.23
483
2004
(3004119) Hemoglobin [Mass/volume] in Venous blood
3614
17331
1.09
5.52
3.6
3.5
g/l
130.1
128.8
2.67
3529
16940
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
375
1493
1.31
5.50
1.5
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
95
285
1.74
5.49
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
470
1928
1.27
5.49
1.0
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
565
2369
1.25
5.48
1.9
2.0
g/24h
1.1
1.0
0.12
32
137
(3023183) Ammonium ion [Moles/volume] in Plasma
1360
6173
1.15
5.48
2.8
2.7
umol/l
33.5
34.1
0.36
1150
5207
(3020191) Ethanol [Moles/volume] in Serum or Plasma
600
2536
1.24
5.42
1.5
1.4
promille
1.4
1.4
0.47
458
1943
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
650
2771
1.22
5.42
1.4
1.6
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
27
47
3.00
5.41
1.0
1.0
u/ml
1.4
0.3
0.65
20
34
(3013466) aPTT in Blood by Coagulation assay
63
166
1.98
5.40
1.0
1.1
s
36.0
37.6
0.95
53
145
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
1575
9297
0.88
5.38
1.5
1.6
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
354
1404
1.32
5.35
1.1
1.2
u/ml
9.3
13.1
0.28
43
135
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
1789
8284
1.13
5.35
4.0
4.5
mg/l
1.5
1.5
1.83
1650
7658
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
79
227
1.82
5.28
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
232
863
1.40
5.27
1.7
1.9
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
262
995
1.37
5.27
2.1
2.0
mg/l
8.9
9.3
0.56
214
799
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
1965
9160
1.12
5.26
1.4
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
199
720
1.44
5.26
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
3141
15004
1.10
5.25
2.8
3.4
u/ml
38.9
55.6
2.49
3025
14499
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
472
1949
1.26
5.25
1.2
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
166
580
1.49
5.23
1.3
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
197
713
1.44
5.21
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
465
1920
1.26
5.18
1.0
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
634
2710
1.22
5.17
1.5
1.5
%
31.8
30.3
0.46
398
1705
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
448
1842
1.27
5.17
2.6
3.5
nmol/l
103.1
137.9
1.72
437
1815
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
419
1709
1.28
5.16
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
1969
9195
1.12
5.13
1.4
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
215
794
1.41
5.11
1.8
1.7
au/ml
131.5
139.0
0.07
27
101
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
1972
9213
1.12
5.10
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
1973
9219
1.12
5.09
1.4
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
2466
11682
1.10
4.93
4.9
5.0
%
1.7
1.7
0.87
2297
10988
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
485
2028
1.25
4.88
1.2
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
50
126
2.07
4.85
1.1
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
398
1627
1.28
4.85
1.7
1.8
u/field
2.6
2.4
0.18
280
1169
(3007930) Methemoglobin/Hemoglobin.total in Blood
2421
11473
1.10
4.81
4.9
5.1
%
0.9
0.9
3.89
2258
10781
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
1204
7174
0.87
4.80
1.5
1.5
—
—
—
0
0
(4146454)
670
2906
1.20
4.76
2.6
2.8
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
559
2382
1.23
4.74
1.2
1.2
nmol/l
388.0
358.8
2.47
475
1984
(3003721) Smooth muscle Ab [Units/volume] in Serum
65
182
1.86
4.74
1.1
1.1
u/ml
3.1
2.6
—
5
18
(3028626) Oxygen [Partial pressure] in Capillary blood
1636
7599
1.13
4.71
4.1
4.1
kpa
8.5
8.5
0.37
1512
7123
(3027923) C peptide [Moles/volume] in Serum or Plasma
372
1514
1.28
4.71
1.7
1.5
nmol/l
1.2
1.2
0.03
291
1193
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
200
742
1.41
4.67
1.7
2.0
u/l
20.6
43.0
3.10
180
670
(3051387) C reactive protein [Mass/volume] in Capillary blood
1379
6347
1.14
4.61
3.7
3.2
mg/l
24.2
27.6
2.61
790
4128
(3015235) Bicarbonate [Moles/volume] in Capillary blood
1606
7464
1.12
4.59
3.1
3.2
mmol/l
24.5
24.6
0.30
1404
6604
(4198724)
388
1594
1.27
4.57
2.9
2.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
404
1668
1.26
4.57
1.2
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
590
2540
1.21
4.55
1.4
1.3
nmol/l
1.4
1.4
0.02
524
2304
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
97
310
1.63
4.54
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
76
227
1.75
4.54
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6001
29556
1.06
4.53
3.3
3.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
953
4282
1.16
4.50
1.3
1.3
mmol/l
7.1
7.1
0.12
696
3050
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
95
303
1.64
4.49
1.1
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
255
992
1.34
4.48
1.5
1.4
pmol/l
14.5
14.9
0.62
208
836
(3048879) Bone marrow aspiration report
202
757
1.39
4.48
1.8
1.9
—
—
—
0
0
(3003843) Paprika IgE Ab [Units/volume] in Serum
26
50
2.71
4.46
1.0
1.0
u/ml
0.1
0.0
0.59
21
38
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
735
3239
1.18
4.41
1.1
1.1
%
94.9
95.3
0.18
682
3030
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
190
707
1.40
4.39
1.3
1.3
%
34.3
38.5
0.70
123
484
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
329
1332
1.29
4.37
1.0
1.1
%
97.3
96.8
0.10
272
1048
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
29
60
2.52
4.36
1.1
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
68
199
1.78
4.36
1.1
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
273
1078
1.32
4.35
2.5
2.8
au/ml
119.3
168.2
0.72
33
148
(3017958) Strawberry IgE Ab [Units/volume] in Serum
33
73
2.36
4.35
1.0
1.0
u/ml
0.1
0.0
0.69
18
41
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
313
1260
1.30
4.34
2.6
2.4
umol/l
53.1
54.7
0.44
262
1049
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
53
143
1.93
4.34
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
194
727
1.39
4.32
1.3
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
181
672
1.41
4.26
1.7
1.7
mmol/l
0.4
0.5
0.03
172
627
(3010015) Selenium [Moles/volume] in Serum or Plasma
81
252
1.68
4.22
2.1
2.2
umol/l
1.3
1.3
0.26
76
222
(3020123) Porphyrins [Interpretation] in Serum or Plasma
55
152
1.89
4.21
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
2084
9875
1.10
4.21
1.5
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
64
186
1.79
4.21
1.1
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
356
1465
1.27
4.18
1.1
1.1
u/l
79.0
88.0
1.08
288
1155
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
356
1465
1.27
4.18
1.1
1.1
u/l
20.7
26.5
0.73
279
1108
(3021661) Pineapple IgE Ab [Units/volume] in Serum
17
26
3.41
4.15
1.0
1.0
u/ml
0.1
0.3
—
9
13
(3036603) Volume of Urine
454
1923
1.23
4.14
1.6
1.6
ml
2074.4
1923.7
0.74
94
455
(3019897) Erythrocyte distribution width [Ratio] by Automated count
944
4272
1.15
4.09
2.6
2.5
%
13.2
13.1
0.40
934
4214
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
59
169
1.82
4.07
1.1
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
677
2994
1.18
3.95
1.4
1.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
62
183
1.77
3.91
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
126
445
1.48
3.89
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
2027
9633
1.10
3.89
3.3
3.4
u/ml
0.4
0.3
0.44
1160
5472
(3042517) Benzodiazepines panel - Urine
111
382
1.52
3.88
2.5
3.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
13
17
3.99
3.86
1.2
1.0
—
—
—
0
0
(3017166) Chili Pepper IgE Ab [Units/volume] in Serum
21
39
2.81
3.86
1.0
1.0
u/ml
0.1
0.1
0.27
16
28
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
61
180
1.77
3.85
1.0
1.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
63
188
1.75
3.84
1.4
1.4
umol/l
89.0
81.1
0.69
58
170
(3032352) Blasts [#/volume] in Cerebral spinal fluid
90
296
1.59
3.83
2.2
2.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
168
629
1.39
3.81
1.1
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
75
236
1.66
3.79
1.3
1.2
nmol/l
17.7
15.6
0.45
25
59
(3017461) Flecainide [Moles/volume] in Serum or Plasma
53
151
1.83
3.75
1.7
1.8
umol/l
0.7
0.7
0.10
40
117
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
1034
4744
1.14
3.72
1.1
1.1
iu/ml
1747.0
2661.0
0.15
234
1061
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
133
480
1.45
3.70
1.2
1.4
ng/l
81.6
285.9
0.60
86
304
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
21
40
2.74
3.70
1.2
1.4
—
—
—
0
0
(4281824)
510
3175
0.84
3.69
1.2
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
135
489
1.44
3.69
2.1
2.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
340
1416
1.25
3.67
3.0
3.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
912
4156
1.15
3.64
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
1347
6293
1.12
3.62
1.7
1.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
421
1798
1.22
3.62
1.6
1.5
u/l
5.5
6.3
0.57
215
870
(3051101) Glucose [Moles/volume] in Cord blood
63
536
0.61
3.60
6.8
5.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
296
1216
1.27
3.59
2.2
2.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
633
2811
1.18
3.57
2.1
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
18
32
2.93
3.56
2.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
18
32
2.93
3.56
1.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
18
32
2.93
3.56
2.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
18
32
2.93
3.56
1.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
18
32
2.93
3.56
1.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
18
32
2.93
3.56
2.0
2.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
149
554
1.40
3.55
1.7
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
60
181
1.73
3.55
1.1
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
290
1191
1.27
3.54
3.1
3.3
mg/l
7.9
8.1
0.16
238
940
(21491868) Cryoglobulin [Mass/volume] in Serum
245
985
1.30
3.52
1.2
1.2
g/l
0.7
0.5
0.22
15
60
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
434
1866
1.21
3.50
1.4
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
437
1881
1.21
3.49
1.1
1.1
ratio
1.1
1.1
1.41
138
700
(3027273) Bicarbonate [Moles/volume] in Venous blood
2853
13834
1.08
3.47
3.5
3.5
mmol/l
25.3
25.2
0.77
2765
13405
(4133840)
207
816
1.32
3.44
1.2
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
323
1349
1.25
3.43
31.1
27.3
ug/l
115.8
119.9
0.50
277
1121
(3019174) dRVVT (LA screen)
77
252
1.59
3.39
1.2
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
364
1543
1.23
3.39
2.0
2.3
umol/l
32.9
47.6
0.73
34
183
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
398
1703
1.22
3.39
1.3
1.2
u/l
23.0
25.5
0.39
341
1470
(3009871) Measles virus Ab [Titer] in Serum
240
969
1.29
3.37
1.7
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
754
3412
1.15
3.36
6.4
8.4
mmol/l
7.7
7.3
0.76
629
2790
(3042111) Morphology [Interpretation] in Bone marrow Narrative
966
4446
1.13
3.36
1.6
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
2458
11867
1.08
3.35
1.5
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
166
636
1.36
3.34
1.1
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
51
150
1.77
3.31
4.1
5.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
193
758
1.33
3.31
1.4
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
908
4172
1.14
3.26
1.7
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
1037
6068
0.89
3.25
3.4
3.3
mmol/l
7.4
7.6
1.19
1017
5961
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
172
666
1.35
3.25
1.2
1.2
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
39
106
1.92
3.22
1.1
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
396
1707
1.21
3.16
1.3
1.4
mmol/l
5.7
5.6
0.25
375
1620
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5804
28875
1.05
3.14
3.7
4.1
ug/l
19.7
24.3
0.67
4619
23220
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
78
2.07
3.14
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
118
432
1.42
3.12
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
175
685
1.33
3.10
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
280
1167
1.25
3.08
2.5
2.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
136
512
1.39
3.08
1.7
1.5
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
405
1755
1.20
3.07
1.3
1.2
u/l
80.7
97.3
2.91
355
1540
(3013247) Albumin in CSF/Albumin in Serum or Plasma
167
651
1.34
3.04
1.1
1.1
mg/g
6.7
7.1
0.24
160
616
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
1393
6589
1.10
3.04
1.5
1.4
pmol/l
109.3
136.3
1.98
1350
6426
(3036048) Francisella tularensis Ab [Titer] in Serum
169
661
1.33
3.02
1.1
1.2
titre
304.0
568.6
—
5
37
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
37
102
1.89
2.96
1.1
1.0
u/ml
0.1
0.1
0.15
19
33
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
50
152
1.72
2.94
1.1
1.1
u/l
49.3
101.8
0.59
41
114
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
52
160
1.69
2.94
2.1
1.5
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
59
188
1.64
2.93
1.1
1.1
u/ml
27.8
24.8
—
9
34
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
59
188
1.64
2.93
1.1
1.1
u/ml
33.0
38.3
0.15
13
40
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
216
879
1.28
2.91
1.1
1.1
—
—
—
0
0
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
21
46
2.38
2.91
1.0
1.0
u/ml
11.8
11.0
0.04
16
34
(3026470) Cobalt [Mass/volume] in Blood
372
1609
1.21
2.90
2.1
2.0
ug/l
3.1
4.0
2.01
333
1421
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
783
3594
1.14
2.90
2.5
2.5
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
79
271
1.52
2.90
1.3
1.2
mmol/l
5.6
6.2
0.46
38
140
(3016650) Hepatitis A virus Ab [Presence] in Serum
1082
5067
1.11
2.88
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
113
418
1.41
2.85
1.5
1.6
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
27
67
2.10
2.85
1.0
1.4
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
178
1200
0.77
2.83
2.6
2.4
nmol/l
151.1
151.1
0.00
156
1036
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
7
110
0.33
2.82
2.3
2.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
77
265
1.52
2.80
1.2
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
38
108
1.83
2.79
1.4
1.7
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
16
31
2.69
2.79
1.4
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
79
274
1.50
2.78
1.2
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
62
204
1.59
2.74
1.2
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
476
2117
1.17
2.74
1.3
1.4
umol/l
12.0
12.3
0.44
452
2002
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
650
2960
1.15
2.74
1.4
1.4
mmol/l
11.4
12.0
0.77
172
680
(3041672) Baker's yeast Ab [Presence] in Serum
47
144
1.70
2.72
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
75
259
1.51
2.70
1.1
1.1
umol/24h
1.8
1.7
0.11
75
259
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
85
302
1.47
2.68
1.8
1.7
mg/l
1.6
1.7
0.35
72
255
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
111
416
1.39
2.64
1.1
1.1
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
26
66
2.05
2.62
4.7
5.0
mg/l
5.3
5.6
0.07
17
53
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
239
1000
1.25
2.61
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
2087
10125
1.08
2.60
1.4
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
151
596
1.32
2.59
1.4
1.4
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
39
115
1.77
2.58
1.0
1.0
u/ml
0.2
0.1
0.39
20
42
(3013166) Neutrophils/100 leukocytes in Synovial fluid
211
872
1.26
2.56
1.3
1.4
%
53.4
55.6
0.36
177
754
(3025577) Chromium [Mass/volume] in Blood
359
1569
1.19
2.56
2.2
2.0
ug/l
2.0
2.4
2.04
293
1327
(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum
28
74
1.97
2.55
1.0
1.0
u/ml
0.2
0.2
—
8
14
(36303858) Crystals [Presence] in Urine
17
36
2.46
2.54
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
1156
5474
1.10
2.54
2.8
2.9
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
32
89
1.87
2.53
1.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
333
1447
1.20
2.53
5.7
5.9
u/ml
292.6
3256.6
0.75
63
291
(3028717) Thiamine [Mass/volume] in Blood
79
281
1.47
2.50
1.1
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
38
113
1.75
2.46
1.3
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
52
169
1.60
2.45
1.3
1.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
80
287
1.45
2.43
3.3
2.9
mg/l
1.0
1.4
1.46
60
193
(44806420)
116
809
0.75
2.43
2.3
2.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
320
1393
1.20
2.41
1.5
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
163
659
1.29
2.39
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
163
659
1.29
2.39
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
163
659
1.29
2.39
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
163
659
1.29
2.39
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
379
1677
1.18
2.38
1.2
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
84
306
1.43
2.37
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
737
3421
1.12
2.36
1.9
1.9
ug/l
21.4
26.2
1.82
720
3352
(3008037) Lactate [Moles/volume] in Venous blood
1123
6418
0.91
2.36
3.3
3.2
mmol/l
1.5
1.6
1.50
1097
6289
(3027456) Digoxin [Moles/volume] in Serum or Plasma
1074
5092
1.10
2.33
3.1
3.1
nmol/l
0.8
0.8
0.08
820
3926
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
729
3385
1.12
2.33
1.2
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
240
1020
1.23
2.32
1.3
1.2
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
54
180
1.56
2.32
1.6
1.3
pmol/l
17.5
17.2
0.05
46
152
(3027035) Albumin [Mass/time] in 24 hour Urine
72
256
1.47
2.31
1.3
1.3
mg/24h
211.8
412.6
—
6
39
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
99
375
1.38
2.26
1.2
1.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
101
384
1.37
2.26
1.0
1.1
ug/l
82.2
78.7
0.39
85
312
(3004446) Plasmodium sp identified in Blood by Light microscopy
86
318
1.41
2.26
2.7
2.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
57
194
1.53
2.25
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
515
2347
1.15
2.23
1.2
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
245
1050
1.22
2.20
1.1
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
292
1273
1.20
2.20
2.3
2.4
mmol/l
9.1
9.3
0.33
213
936
(3004775) Volume in Urine collected for unspecified duration
398
2407
0.86
2.20
2.4
2.3
ml
697.7
663.9
0.78
262
1659
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
44
142
1.62
2.17
1.2
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
316
1390
1.19
2.16
32.7
37.2
ug/l
7.3
7.3
0.12
279
1276
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
20
50
2.09
2.13
1.2
1.1
%
1.8
3.0
1.71
20
50
(3027315) Oxygen [Partial pressure] in Blood
1446
6982
1.08
2.12
3.9
4.0
kpa
8.8
8.6
1.37
1416
6807
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
187
783
1.25
2.10
1.2
1.2
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
14
30
2.43
2.07
1.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
89
337
1.38
2.07
1.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
102
395
1.35
2.07
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
104
404
1.34
2.06
1.3
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
320
1416
1.18
2.06
1.1
1.1
miu/ml
1579.5
1497.7
0.59
320
1416
(3042951) Complement C1q Ab [Units/volume] in Serum
40
128
1.63
2.05
1.0
1.2
u/ml
28.7
17.0
—
5
27
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
96
369
1.36
2.04
1.2
1.1
—
—
—
0
0
(3020934) Sesame Seed IgE Ab [Units/volume] in Serum
13
27
2.51
2.04
1.0
1.0
u/ml
0.3
5.7
—
7
11
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
184
773
1.24
2.03
1.6
1.6
ug/l
8.8
9.2
0.61
184
773
(43055442) Apixaban [Mass/volume] in Serum or Plasma
92
352
1.36
2.02
1.6
1.6
ug/l
116.0
111.7
0.14
81
282
(40762814) Titanium [Mass/volume] in Blood
111
438
1.32
2.00
2.4
2.3
ug/l
4.0
3.7
0.18
48
152
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
57
200
1.49
1.99
3.0
3.1
pmol/l
29.4
446.8
0.62
21
66
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
96
371
1.35
1.98
2.7
2.6
pmol/l
71.5
68.2
0.08
84
321
(3010421) pH of Blood
1635
7955
1.07
1.98
3.8
3.9
ph
7.4
7.4
1.78
1405
6773
(40768795) Lymph node Pathology biopsy report
598
2778
1.12
1.96
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
1433
6941
1.08
1.96
3.8
4.0
mmol/l
2.4
2.5
1.06
984
4624
(3013290) Carbon dioxide [Partial pressure] in Blood
1433
6943
1.08
1.95
3.9
4.0
kpa
5.0
5.0
0.27
1403
6769
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
37
118
1.64
1.94
1.7
1.5
u/l
0.2
0.2
—
9
36
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
16
38
2.20
1.93
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
250
1090
1.20
1.93
2.6
2.3
—
—
—
0
0
(4034850)
1944
9524
1.07
1.93
10.0
9.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
178
750
1.24
1.93
1.2
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
78
293
1.39
1.92
1.1
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
126
510
1.29
1.90
3.3
5.1
u/l
38.3
56.8
1.37
42
205
(3033705) Calcium.ionized [Moles/volume] in Venous blood
619
3596
0.90
1.88
2.5
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6432
32464
1.04
1.88
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
256
1122
1.19
1.88
2.1
2.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
235
1026
1.19
1.81
3.0
2.9
umol/l
27.7
28.9
0.83
189
761
(40768793) Breast Pathology biopsy report
1291
6259
1.08
1.76
1.3
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
105
420
1.30
1.76
1.2
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
45
155
1.51
1.75
1.0
1.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
153
643
1.24
1.73
1.4
1.4
%
23.8
22.1
0.29
134
529
(40762887) Creatinine [Moles/volume] in Blood
19
51
1.94
1.73
1.2
1.2
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
47
164
1.49
1.73
1.0
1.1
u/l
2.0
3.0
—
7
38
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
145
606
1.25
1.73
1.9
1.8
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
42
143
1.53
1.72
1.8
1.6
ng/l
193.1
207.2
0.45
34
125
(1616796) Gas panel - Central venous blood
1400
6816
1.07
1.71
3.5
3.6
—
—
—
0
0
(3015057) Respiratory syncytial virus Ab [Titer] in Serum
5
6
4.34
1.67
1.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
157
665
1.23
1.67
1.2
1.3
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
7
85
0.43
1.64
3.3
2.6
umol/l
31.9
36.2
—
7
78
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
320
1448
1.15
1.63
1.2
1.3
%
69.0
62.7
0.48
31
176
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
7
12
3.04
1.63
1.1
1.0
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
7
12
3.04
1.63
1.1
1.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
309
1396
1.15
1.61
1.5
1.5
%
4.8
4.0
0.42
67
322
(40758047) Lysozyme [Mass/volume] in Pleural fluid
63
237
1.39
1.59
1.3
1.1
mg/l
8.9
9.1
0.06
54
224
(3016228) CD19 cells/100 cells in Blood
258
1152
1.17
1.58
2.1
2.0
%
8.9
8.4
0.21
253
1120
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
137
576
1.24
1.58
1.3
1.2
mg/l
48.8
46.7
0.02
104
418
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
34
113
1.57
1.57
1.2
1.1
u/l
257.1
458.3
0.90
28
98
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
69
265
1.36
1.55
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
571
2689
1.11
1.55
1.3
1.3
—
—
—
0
0
(3026926) Nortriptyline [Moles/volume] in Serum or Plasma
22
65
1.76
1.54
1.4
1.6
nmol/l
385.9
188.0
0.57
15
47
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
48
173
1.45
1.54
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
269
1208
1.16
1.54
1.2
1.3
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
103
421
1.28
1.51
1.4
1.4
nmol/l
197538.0
213474.5
0.04
81
349
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
65
249
1.36
1.50
1.4
1.4
ml/s/173m2
1.1
1.2
0.50
44
164
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
6
10
3.13
1.49
1.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
459
2144
1.12
1.47
1.4
1.4
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
9
19
2.47
1.46
1.6
1.9
%
13.3
21.5
—
9
19
(3016750) Collection duration of Urine
300
1786
0.88
1.45
2.3
2.1
min
497.2
500.5
0.24
219
1331
(43055514) Macroprolactin [Presence] in Serum or Plasma
197
868
1.18
1.44
1.4
1.4
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
10
22
2.37
1.44
1.1
5.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
1160
5654
1.07
1.43
3.1
3.4
u/ml
395.6
874.8
1.93
1045
5138
(3017509) Phencyclidine [Presence] in Urine
94
383
1.28
1.43
1.3
2.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
244
1095
1.16
1.43
1.0
1.0
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
114
476
1.25
1.42
1.1
1.1
pmol/l
2.4
8.1
0.76
17
53
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
55
207
1.39
1.42
3.5
2.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
99
407
1.27
1.41
1.5
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
322
1477
1.14
1.40
2.1
2.2
ml
2020.4
1941.0
0.64
291
1314
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
476
2235
1.11
1.40
1.6
1.5
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
16
44
1.90
1.40
1.1
1.2
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
62
239
1.35
1.39
1.0
1.1
—
2.8
—
0
10
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
303
1385
1.14
1.39
1.2
1.2
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
260
1177
1.15
1.37
1.5
1.4
%
73.6
72.9
0.37
245
1122
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
25
80
1.63
1.36
4.7
6.7
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
25
80
1.63
1.36
3.1
3.4
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
53
200
1.38
1.36
1.1
1.1
u/l
7.2
11.1
1.42
53
200
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
255
1154
1.15
1.36
1.5
1.4
mu/l
1029.9
594.0
0.48
240
1099
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
1423
6998
1.06
1.36
2.4
2.4
ug/min
104.6
115.1
0.36
828
4203
(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum
5
8
3.26
1.35
1.0
1.3
—
—
—
0
0
(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid
5
8
3.26
1.35
2.8
1.8
—
—
—
0
0
(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum
5
8
3.26
1.35
1.0
1.3
—
—
—
0
0
(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum
5
8
3.26
1.35
1.0
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
99
410
1.26
1.34
2.4
2.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
68
268
1.32
1.34
1.0
1.1
—
—
—
0
0
(3033942) Copper [Moles/time] in 24 hour Urine
37
131
1.47
1.33
1.2
1.2
umol/24h
0.8
0.9
0.08
19
59
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
4725
23891
1.03
1.32
3.8
3.9
mmol/l
1.2
1.2
0.35
4151
20791
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
107
449
1.24
1.31
1.1
1.1
—
—
—
0
0
(3002853) Influenza virus B Ab [Titer] in Serum
8
17
2.45
1.30
1.0
1.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
574
2734
1.10
1.29
1.6
1.6
mmol/l
7.7
7.6
0.53
369
1583
(3036005) Urine sediment comments by Light microscopy Narrative
11
27
2.12
1.28
1.1
1.1
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
11
27
2.12
1.28
1.0
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
312
1439
1.13
1.28
1.5
1.6
iu/ml
1674396.7
1995281.8
0.21
24
100
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
39
141
1.44
1.27
1.2
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
122
770
0.83
1.26
1.2
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
271
1241
1.14
1.24
1.7
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
855
4149
1.08
1.24
2.8
2.8
u/ml
87.6
859.5
1.96
813
3956
(3006598) pH of Arterial cord blood
47
332
0.74
1.23
1.0
1.0
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
31
108
1.50
1.22
1.0
1.1
mg/l
0.0
0.4
0.51
25
97
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
305
1410
1.13
1.22
1.5
1.6
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
13
35
1.94
1.22
1.0
1.1
—
—
—
0
0
(3025481) Topiramate [Mass/volume] in Serum or Plasma
0
20
0.00
1.21
0.0
2.5
—
5.6
—
0
14
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
305
1411
1.13
1.21
1.5
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
174
1059
0.86
1.20
2.6
2.9
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
81
333
1.27
1.20
1.3
1.3
u/l
52.2
287.0
1.00
59
238
(3022475) Manganese [Moles/volume] in Blood
46
174
1.38
1.19
1.3
1.3
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
47
330
0.74
1.19
1.0
1.0
mmol/l
-1.8
-1.4
—
8
64
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
54
210
1.34
1.19
1.5
1.4
%
30.1
41.2
1.05
34
142
(3020618) Glucose [Moles/volume] in Synovial fluid
28
96
1.52
1.19
1.0
1.1
mmol/l
6.1
5.0
0.87
18
68
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
14
2.61
1.18
1.1
1.1
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
7
14
2.61
1.18
1.1
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
85
353
1.26
1.17
4.1
3.0
umol/l
42.3
41.3
0.15
73
300
(3049242) von Willebrand panel - Platelet poor plasma
25
84
1.55
1.16
2.2
1.6
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
36
261
0.72
1.13
3.9
2.0
%
52.9
59.7
0.53
25
160
(3018133) Calcium [Moles/volume] in Urine
128
558
1.20
1.12
2.4
2.2
mmol/l
2.5
2.7
0.52
117
504
(37019676) Renin [Units/volume] in Plasma --supine
20
64
1.63
1.12
1.3
1.0
mu/l
44.5
63.9
0.32
12
48
(3014891) Appearance of Pleural fluid
61
409
0.78
1.12
1.9
1.6
—
—
—
0
0
(44806071)
92
388
1.24
1.12
1.1
1.1
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
25
85
1.53
1.11
1.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
73
301
1.26
1.08
1.1
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
79
329
1.25
1.08
3.6
2.9
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
44
169
1.36
1.07
1.3
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
130
571
1.19
1.06
1.2
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
70
288
1.27
1.06
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
402
1906
1.10
1.06
1.3
1.3
g/l
1.4
1.5
0.61
31
104
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
28
209
0.70
1.05
4.6
1.9
%
17.8
16.1
0.13
18
100
(40767503) Oxygen content in Capillary blood by calculation
1310
6486
1.05
1.05
2.5
2.5
%
16.6
16.4
0.85
695
3327
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
10
26
2.01
1.03
1.1
1.3
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
32
117
1.43
1.03
1.2
1.1
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
78
327
1.24
1.02
1.4
1.4
%
71.4
71.5
0.00
66
274
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
25
87
1.50
1.02
1.0
1.1
mmol/l
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
20
66
1.58
1.01
2.2
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
86
365
1.23
1.01
1.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
87
370
1.23
1.00
1.7
1.9
mmol/l
7.6
7.3
0.15
26
144
(4212803)
58
235
1.29
1.00
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
291
1362
1.11
1.00
1.3
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
2544
12805
1.04
0.99
4.0
4.1
%
49.7
48.0
2.74
2515
12662
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
433
2069
1.09
0.98
1.3
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
170
1017
0.87
0.98
1.5
1.4
%
62.3
62.8
0.06
139
826
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
131
582
1.17
0.97
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
279
1307
1.11
0.95
5.8
11.3
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
10
27
1.93
0.95
1.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
144
869
0.86
0.95
3.3
3.1
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
18
59
1.59
0.95
1.3
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
983
4848
1.06
0.94
1.8
1.9
mmol/l
1.7
1.8
0.73
968
4728
(3046904) Somatotropin [Units/volume] in Serum or Plasma
17
55
1.61
0.94
3.8
2.2
mu/l
2.1
2.4
0.19
17
55
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
17
55
1.61
0.94
1.0
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
144
868
0.86
0.94
6.6
6.2
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
16
51
1.64
0.93
1.9
2.3
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
15
47
1.66
0.93
1.1
1.1
—
—
—
0
0
(3030940) RBC casts [#/area] in Urine by Computer assisted method
6
14
2.23
0.92
1.2
1.0
—
—
—
0
0
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
6
14
2.23
0.92
1.2
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
77
327
1.23
0.92
1.2
1.5
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
38
147
1.35
0.91
1.1
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
79
337
1.22
0.91
3.6
2.9
mg/l
20.7
23.6
1.41
73
316
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
53
350
0.79
0.91
6.4
7.5
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
73
464
0.82
0.89
1.2
1.2
mmol/l
20.3
20.5
0.17
59
397
(40758292) HTLV I+II Ab panel - Serum
113
501
1.18
0.88
1.4
1.4
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
83
358
1.21
0.87
5.0
5.3
g/mol
70.8
179.7
0.38
74
331
(3040794) Aluminum [Moles/volume] in Urine
12
36
1.74
0.86
1.2
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
359
1715
1.09
0.86
1.0
1.0
ng/l
303.8
320.6
0.55
258
1208
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
90
392
1.20
0.86
2.7
2.1
mmol/l
1.5
1.4
0.03
61
281
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
73
312
1.22
0.84
1.2
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
37
145
1.33
0.84
1.1
1.1
—
—
—
0
0
(3017950) Salicylates [Moles/volume] in Serum or Plasma
20
70
1.49
0.82
1.5
1.9
umol/l
1961.0
1303.3
—
5
12
(3013862) HLA-DP [Type]
28
105
1.39
0.82
1.0
1.0
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
36
141
1.33
0.82
1.3
1.3
mg/l
1.7
1.6
0.19
28
119
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
92
404
1.19
0.81
1.3
1.3
%
55.4
50.3
0.42
44
189
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
18
62
1.51
0.80
5.7
5.4
mmol/l
0.3
0.2
1.18
18
62
(3041184) Isoniazid [Presence] in Urine
11
33
1.74
0.79
2.5
2.6
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
125
565
1.15
0.79
1.4
1.6
nmol/l
0.2
0.2
0.39
90
408
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
498
2422
1.07
0.79
1.9
2.0
u/field
1.8
2.4
1.25
240
1042
(3043238) Trisomy 21 risk [Likelihood] in Fetus
1550
7776
1.04
0.78
1.5
1.5
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
133
605
1.15
0.77
4.7
6.2
%
69.8
70.1
0.04
104
480
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
106
474
1.17
0.77
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
489
2380
1.07
0.76
1.8
1.7
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
62
264
1.22
0.76
1.2
1.2
mg/l
52.0
43.9
0.88
24
68
(3032868) Hemoglobin electrophoresis panel in Blood
66
283
1.22
0.76
1.6
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
1515
7606
1.04
0.74
1.5
1.5
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
27
103
1.37
0.74
1.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
1189
5943
1.04
0.73
1.8
2.1
nmol/l
0.9
0.8
1.14
990
4980
(4038314)
55
233
1.23
0.72
1.1
1.2
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
13
2.01
0.71
1.2
1.1
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
21
77
1.42
0.71
1.3
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
124
566
1.14
0.71
2.2
2.5
mmol/l
8.0
7.3
0.78
86
334
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
358
1729
1.08
0.71
1.0
1.0
ng/l
764.9
736.6
0.54
248
1170
(44786800) Granulocytes/100 leukocytes in Body fluid
58
366
0.83
0.70
1.3
1.3
%
38.6
21.6
2.63
47
281
(3041918) Cholesterol [Moles/volume] in Pleural fluid
110
498
1.15
0.70
1.3
1.2
mmol/l
1.6
1.7
0.22
73
297
(3042010) Triglyceride [Moles/volume] in Pleural fluid
88
392
1.17
0.69
1.3
1.3
mmol/l
1.1
1.3
0.11
57
248
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
404
1963
1.07
0.69
1.8
1.8
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
47
197
1.24
0.68
1.3
1.4
umol/24h
287.8
327.4
1.06
47
197
(3005033) Fetal Nuchal fold Thickness US
1509
7593
1.04
0.68
1.5
1.5
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
107
485
1.15
0.68
3.0
3.0
ml/dl
15.0
14.7
0.42
96
453
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
137
632
1.13
0.68
2.8
2.5
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
45
188
1.25
0.67
1.5
1.4
%
12.7
13.5
0.09
33
132
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
42
174
1.26
0.67
1.1
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
27
105
1.34
0.67
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
27
105
1.34
0.67
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
27
105
1.34
0.67
1.0
1.0
—
—
—
0
0
(3044590) Delta aminolevulinate [Moles/volume] in Urine
5
14
1.86
0.67
1.0
1.1
umol/l
18.8
16.4
—
5
14
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
14
1.86
0.67
1.4
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
291
1644
0.92
0.66
1.4
1.5
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
14
48
1.52
0.65
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
256
1225
1.09
0.65
1.9
1.8
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
149
868
0.89
0.65
1.5
1.4
%
1.7
2.9
2.01
124
720
(3026692) Albumin [Mass/volume] in Peritoneal fluid
124
730
0.89
0.64
1.4
1.4
g/l
13.2
13.7
0.28
98
546
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
357
1733
1.07
0.64
1.0
1.0
ng/l
42.1
42.1
0.00
251
1199
(3022689) Creatine [Moles/volume] in Urine
176
828
1.11
0.64
1.6
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
291
1403
1.08
0.63
2.1
2.1
ug/min
149.2
95.9
0.22
54
338
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
26
102
1.33
0.62
1.2
1.1
nmol/l
267.0
268.8
0.02
26
102
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
31
125
1.29
0.62
1.1
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
55
238
1.20
0.61
1.3
1.3
pmol/l
7.6
15.1
1.66
45
199
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
11
36
1.59
0.61
1.0
1.0
—
—
—
0
0
(3032641) Amino acids panel - Urine
7
60
0.61
0.61
1.6
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
686
3754
0.95
0.60
2.0
2.2
pg
32.6
32.6
0.05
681
3724
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
16
58
1.44
0.59
1.1
1.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
62
380
0.85
0.58
1.0
1.0
mu/l
8.5
8.8
0.11
52
321
(3046914) Granular casts [#/area] in Urine by Computer assisted method
15
54
1.45
0.58
1.7
1.3
u/field
0.6
0.7
—
7
32
(3006576) Bicarbonate [Moles/volume] in Blood
218
1044
1.09
0.57
5.0
6.4
mmol/l
25.5
24.9
1.88
204
943
(3015350) Toxocara sp Ab [Presence] in Serum
9
30
1.56
0.57
1.0
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
176
835
1.10
0.56
1.3
1.3
mmol/l
3.4
3.5
0.20
154
774
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
116
538
1.12
0.56
1.7
1.8
ug/l
2.0
3.7
0.98
55
344
(3012898) Urea [Moles/volume] in Urine
68
304
1.17
0.55
1.6
1.5
mmol/l
181.9
163.1
0.60
63
268
(3000330) Specific gravity of Urine by Test strip
2852
14556
1.02
0.53
3.6
3.4
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
44
190
1.21
0.52
1.0
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
56
248
1.18
0.52
1.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
97
448
1.13
0.52
1.4
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
474
2602
0.95
0.51
1.5
1.5
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
33
139
1.24
0.50
9.0
6.8
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
179
1015
0.92
0.50
3.4
3.6
%
51.5
52.9
0.38
174
977
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
65
390
0.87
0.49
1.1
1.3
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
7
24
1.52
0.49
1.7
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
35
149
1.22
0.49
1.1
1.2
umol/l
17.4
16.6
0.36
30
128
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
41
178
1.20
0.48
1.1
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
44
193
1.19
0.46
1.4
1.3
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
45
198
1.19
0.46
3.5
4.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
171
821
1.09
0.46
1.4
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
52
232
1.17
0.46
1.1
1.1
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
15
57
1.37
0.46
1.3
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
117
552
1.11
0.45
1.4
1.6
nmol/l
5.2
5.7
0.68
111
525
(3000690) Aldosterone [Moles/time] in 24 hour Urine
5
15
1.74
0.45
1.0
1.3
nmol/24h
22.3
29.8
—
5
15
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
26
108
1.26
0.45
1.0
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
136
775
0.91
0.44
1.4
1.4
%
24.0
21.2
0.53
121
698
(40758358) Immune stain study
28
118
1.24
0.44
1.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
1971
10051
1.02
0.43
3.3
3.5
u/ml
1125.5
2013.4
0.59
1670
8606
(3027114) Cholesterol [Mass/volume] in Serum or Plasma
0
9
0.00
0.43
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
13
49
1.38
0.42
1.1
1.1
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
49
221
1.16
0.39
2.7
2.3
mmol/l
18.6
19.8
0.22
42
189
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
189
919
1.07
0.39
2.0
2.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
17
68
1.30
0.39
1.1
1.2
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
9
35
1.34
0.38
1.1
1.1
mmol/24h
122.9
152.8
—
9
35
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
25
106
1.23
0.38
1.2
1.0
pmol/l
256.5
204.4
0.27
14
57
(3044242) Glucose [Moles/volume] in Arterial blood
273
1346
1.06
0.38
2.4
1.9
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
36
159
1.18
0.37
1.4
1.3
%
2.1
1.4
0.25
24
103
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
43
193
1.16
0.37
1.0
1.0
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
6
21
1.49
0.37
3.5
1.7
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
46
208
1.15
0.37
1.1
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
385
1919
1.05
0.36
11.8
12.2
mmol/l
0.6
0.6
1.21
346
1773
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
12
46
1.36
0.36
1.0
1.0
ng/l
12472.3
10646.5
—
6
15
(3020911) Cortisol [Moles/time] in 24 hour Urine
12
46
1.36
0.36
1.1
1.2
nmol/24h
98.3
98.3
0.00
12
46
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
16
106
0.79
0.36
1.0
1.0
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
30
131
1.19
0.36
1.4
1.3
u/field
1.2
1.1
0.47
17
80
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
72
337
1.11
0.35
1.3
1.2
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
19
79
1.25
0.34
9.0
8.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
268
1326
1.05
0.34
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
907
4600
1.03
0.34
4.8
5.2
umol/l
352.6
370.9
3.17
778
4009
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
53
244
1.13
0.34
3.1
2.9
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
17
70
1.27
0.33
1.3
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
217
1069
1.06
0.33
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
34
152
1.17
0.32
1.3
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
388
2106
0.96
0.32
1.0
1.0
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
47
216
1.13
0.32
1.1
1.2
%
19.6
23.2
0.15
11
55
(40761536) Microorganisms panel - Urine sediment
5083
26779
0.99
0.32
4.2
3.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
781
3960
1.03
0.31
1.8
1.8
%
90.1
89.8
0.58
774
3893
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
93
445
1.09
0.31
5.9
5.0
ug/min
40.4
49.6
0.72
68
358
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
51
236
1.13
0.31
1.2
1.1
iu/ml
25.8
16.2
0.26
13
76
(3003157) Bacteria [#/volume] in Mother's milk
11
75
0.76
0.31
5.8
6.7
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
26
160
0.85
0.31
5.0
14.6
—
—
—
0
0
(3035880) pH of Pleural fluid
301
1501
1.05
0.30
1.3
1.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
399
2002
1.04
0.30
1.3
1.3
u/l
12.7
13.8
0.51
372
1846
(3027540) Rickettsia typhi Ab [Titer] in Serum
8
58
0.72
0.30
1.3
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
28
124
1.18
0.30
3.3
2.5
—
—
—
0
0
(3025315) Body weight
46
270
0.89
0.30
4.6
4.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
161
891
0.94
0.29
2.1
1.9
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
125
0.83
0.28
1.1
1.0
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
51
238
1.12
0.28
1.2
1.2
ug/l
104.9
104.1
0.02
36
143
(3000034) Microalbumin [Mass/volume] in Urine
531
2684
1.03
0.28
2.9
3.0
mg/l
46.6
56.7
0.45
395
1911
(3027696) Helicobacter pylori Ab [Titer] in Serum
10
39
1.34
0.28
1.0
1.1
titre
1297.0
1959.2
—
10
39
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
143
701
1.06
0.27
1.1
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
50
234
1.11
0.27
1.5
1.7
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
502
2538
1.03
0.26
1.4
1.3
u/l
457.9
485.1
0.17
474
2407
(3021691) Plasmodium malariae Ab [Titer] in Serum
9
37
1.27
0.26
3.0
2.3
—
—
—
0
0
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
26
116
1.17
0.26
1.3
1.1
u/field
1.1
1.2
0.15
15
75
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
181
897
1.05
0.25
2.6
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
181
897
1.05
0.25
2.6
2.5
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
39
181
1.12
0.24
1.2
1.1
—
510.0
—
0
6
(3024932) HLA-DR beta [Type]
210
1046
1.05
0.24
1.1
1.1
—
—
—
0
0
(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum
5
19
1.37
0.24
1.0
1.1
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
5
20
1.30
0.23
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
77
432
0.93
0.23
2.6
3.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
46
217
1.11
0.23
5.8
5.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
86
418
1.07
0.23
7.5
7.9
—
—
—
0
0
(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.22
0.0
10.8
—
—
—
0
0
(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid
0
6
0.00
0.22
0.0
1.0
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
46
264
0.91
0.22
3.9
2.9
%
17.6
10.4
—
10
89
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
188
937
1.05
0.22
1.2
1.2
%
19.6
19.9
0.02
27
157
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
8
54
0.77
0.22
2.0
2.0
ng/l
12.2
17.4
—
8
44
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
902
4794
0.98
0.22
1.4
1.3
ug/l
3.7
3.8
0.20
827
4318
(3003694) ABO and Rh group [Type] in Blood
17313
89931
1.00
0.21
1.5
1.5
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
108
531
1.06
0.21
3.1
2.5
mmol/l
1.2
1.2
0.74
103
504
(3034988) Calcium [Moles/volume] in Capillary blood
116
572
1.06
0.21
3.3
2.6
mmol/l
1.2
1.2
0.43
109
548
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
6
25
1.25
0.21
1.0
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
268
1350
1.04
0.20
3.2
4.8
mg/l
4347.7
1978.3
0.73
200
971
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
18
80
1.17
0.20
1.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
245
1233
1.04
0.20
1.2
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
3545
18329
1.01
0.19
1.5
1.5
—
—
—
0
0
(3024316) Viscosity of Plasma
31
145
1.11
0.18
1.3
1.8
mpas
1.8
1.6
0.34
19
89
(3045788) Cell count panel - Pleural fluid
507
2584
1.02
0.18
1.6
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
277
1400
1.03
0.18
3.1
3.4
—
—
—
0
0
(3035082) Kappa light chains [Mass/volume] in Urine
12
75
0.83
0.18
1.3
1.0
g/l
0.6
0.1
—
5
24
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
384
1951
1.03
0.18
2.0
1.9
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
14
86
0.85
0.18
1.1
1.2
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
10
42
1.24
0.17
1.0
1.0
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
5
35
0.74
0.17
6.4
9.4
ug/l
7.5
7.5
—
5
30
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
94
464
1.06
0.17
7.6
7.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
77
426
0.94
0.17
1.6
1.4
%
11.1
11.7
0.08
37
206
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
8
35
1.19
0.17
1.3
1.3
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
8
35
1.19
0.17
1.1
1.1
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
8
35
1.19
0.17
1.3
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
139
752
0.96
0.14
7.1
8.9
—
—
—
0
0
(3035510) Gentamicin [Mass/volume] in Serum or Plasma
16
95
0.88
0.14
4.7
5.6
mg/l
2.1
1.3
0.50
11
66
(3046861) Legionella sp Ag [Presence] in Urine
32
153
1.09
0.14
1.1
1.1
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
49
239
1.07
0.14
1.4
1.4
umol/l
0.2
0.2
0.39
11
90
(3036180) Methadone [Presence] in Urine
14
63
1.16
0.14
3.2
2.7
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
116
582
1.04
0.13
5.8
5.9
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
107
536
1.04
0.13
3.0
2.5
mg/l
81.8
46.2
0.50
15
104
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
504
2672
0.98
0.13
3.7
3.8
u/ml
33.9
53.4
2.55
496
2640
(3011335) Digoxin [Mass/volume] in Serum or Plasma
46
225
1.07
0.12
2.5
2.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
283
1443
1.02
0.12
1.3
1.3
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
50
276
0.94
0.12
1.1
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
38
185
1.07
0.11
1.5
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
253
1291
1.02
0.11
1.2
1.2
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
5
23
1.13
0.10
1.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
12
71
0.88
0.10
1.1
1.1
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
31
173
0.93
0.10
1.5
1.3
u/l
3832.8
472.7
0.70
25
154
(3023487) Leukocytes [#/volume] in Peritoneal fluid
191
1019
0.98
0.10
1.9
2.0
e6/l
5438.1
2647.5
0.30
133
684
(3005082) Progesterone [Moles/volume] in Serum or Plasma
360
1847
1.02
0.10
1.3
1.4
nmol/l
30.3
31.7
0.40
328
1695
(3035611) Eosinophils/100 leukocytes in Synovial fluid
41
202
1.06
0.09
1.6
1.8
%
1.1
0.7
0.34
32
157
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
74
401
0.96
0.09
1.9
2.6
u/field
0.7
0.6
0.25
74
401
(3013762) Body weight Measured
21
119
0.92
0.09
1.1
1.1
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
24
135
0.93
0.09
1.3
1.2
g/l
0.1
0.1
0.81
19
95
(40768800) Prostate Pathology biopsy report
1034
5436
0.99
0.09
1.2
1.2
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
6
29
1.08
0.09
1.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
71
384
0.96
0.08
7.7
10.0
umol/l
0.3
0.4
0.47
61
349
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
54
294
0.96
0.08
1.1
1.1
u/l
23.7
19.9
0.71
36
195
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
73
368
1.03
0.07
1.9
2.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
8
40
1.04
0.07
1.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
31
171
0.95
0.07
3.3
3.5
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
7
44
0.83
0.07
1.3
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
55
276
1.04
0.07
1.3
1.2
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
8
47
0.89
0.07
1.1
1.1
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
22
107
1.07
0.07
1.5
1.3
nmol/l
454.1
494.1
0.12
22
107
(3002331) Protein [Mass/volume] in Peritoneal fluid
120
639
0.98
0.06
1.4
1.3
g/l
23.7
38.2
0.90
89
495
(3044007) Cell count panel - Peritoneal fluid
154
817
0.98
0.06
2.1
1.9
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
651
3369
1.01
0.06
1.5
1.4
e6/l
2438.9
3052.6
0.70
470
2444
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
30
149
1.05
0.05
4.1
4.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
162
857
0.99
0.05
1.6
1.8
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
81
413
1.02
0.04
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
556
2917
0.99
0.04
1.6
1.5
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
19
105
0.94
0.04
1.5
1.1
ng/l
2171.4
3627.1
0.55
11
67
(3003434) Protein [Mass/volume] in Pleural fluid
716
3752
0.99
0.04
1.5
1.4
g/l
32.3
33.0
0.78
650
3369
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
54
289
0.97
0.04
5.9
4.3
mg/l
2.5
2.2
0.43
46
251
(3017569) Oxygen content in Arterial blood
253
1307
1.01
0.04
2.6
2.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
557
2920
0.99
0.03
1.6
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
172
907
0.99
0.03
1.7
1.9
e6/l
22989.0
9621.6
0.53
89
487
(3040893) Potassium [Moles/volume] in Capillary blood
21
115
0.95
0.03
2.0
2.5
mmol/l
4.2
4.4
0.37
21
109
(3036782) Glucose [Moles/volume] in Pleural fluid
503
2637
0.99
0.03
1.4
1.3
mmol/l
6.2
6.3
0.58
464
2438
(3028308) Erythrocytes [#/volume] in Pleural fluid
589
3057
1.00
0.03
1.5
1.4
e6/l
79744.9
50908.0
0.96
330
1855
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
63
322
1.02
0.03
2.1
2.2
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
35
188
0.97
0.03
1.5
1.1
u/field
1.0
1.2
0.99
25
127
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
23
115
1.04
0.02
1.2
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
127
655
1.01
0.02
7.2
9.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
90
463
1.01
0.02
3.3
2.6
u/l
4188.2
1150.4
0.98
85
408
(3022670) pH of Venous cord blood
21
105
1.04
0.02
1.0
1.0
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
139
718
1.01
0.02
3.0
2.5
ng/l
143.9
103.9
0.59
73
397
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
22
119
0.96
0.02
1.0
1.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
27
145
0.97
0.01
4.3
3.9
—
—
—
0
0
(3019977) pH of Arterial blood
311
1628
1.00
0.01
2.8
2.5
ph
7.4
7.4
0.93
96
579
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
23
116
1.03
0.01
10.1
9.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
209
1095
1.00
0.01
4.8
4.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
864
4512
1.00
0.01
1.2
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
12
60
1.04
0.00
1.4
1.5
mmol/24h
2.4
2.0
0.52
12
60
(3027874) Urate [Moles/volume] in Urine
19
97
1.02
0.00
1.1
1.1
mmol/l
1.7
8.0
0.49
13
60
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
73
381
1.00
0.00
3.3
3.1
—
37.4
—
0
5
(3000285) Sodium [Moles/volume] in Blood
70
367
0.99
0.00
1.2
1.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
16
83
1.01
0.00
1.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
36
187
1.00
0.00
1.5
1.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
147
766
1.00
0.00
1.2
1.3
ug/l
304.4
249.2
0.12
79
414
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
11
59
0.97
0.00
6.4
3.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
862
4494
1.00
0.00
3.5
3.5
u/ml
33.9
38.6
0.35
827
4332
(3021367) Citalopram [Moles/volume] in Serum or Plasma
13
66
1.03
0.00
1.4
1.4
nmol/l
107.1
140.4
—
8
39
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
32
167
1.00
0.00
1.0
1.0
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
10
53
0.98
0.00
1.1
1.2
mg/l
27.3
28.4
—
10
47
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
16
86
0.97
0.00
1.0
1.1
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
10
51
1.02
0.00
1.2
1.1
—
—
—
0
0
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
14
74
0.99
0.00
9.0
8.9
%
45.4
45.9
—
5
44
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
31
162
1.00
0.00
15.4
8.9
e6/l
465.3
156.0
0.52
25
119
(3020132) Chylomicrons [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
7
37
0.99
0.00
1.6
1.1
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
6
32
0.98
0.00
1.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint J10_UPPERDIS and mortality.

Females

Parameter HR [95% CI] p-value
J10_UPPERDIS 1.088 [0.99, 1.2] 0.081
Birth year 0.997 [0.99, 1.0] 0.418

During the follow-up period (1.1.1998 — 31.12.2019), 14268 out of 301390 females with J10_UPPERDIS died.

Males

Parameter HR [95% CI] p-value
J10_UPPERDIS 1.073 [0.98, 1.17] 0.12
Birth year 0.986 [0.98, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 19941 out of 308838 males with J10_UPPERDIS died.

Mortality risk

Mortality risk for people of age

years, who have J10_UPPERDIS.

N-year risk Females Males
1 0.067% 0.202%
5 0.59% 1.093%
10 1.547% 2.78%
15 3.131% 5.417%
20 5.62% 9.36%

Relationships between endpoints

↥

Index endpoint: J10_UPPERDIS – Other diseases of upper respiratory tract

GWS hits: 67

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data